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ABSTRACT
EFFECTS OF PROGRESSIVE LENS EYEGLASSES ON GAIT PERFORMANCE
FACTORS AMONG YOUNG AND MIDDLE-AGED GROUPS
by
Autumn M. Milanowski

The University of Wisconsin-Milwaukee, 2012
Under the Supervision of Roger O. Smith & Kurt Beschorner

Background: It is estimated that over 85% of adults over the age of 45 develop a
condition called presbyopia (Holden et al., 2008). Multifocal lenses (MfLs) are used to
functionally adapt to this condition to allow for convenient near and distance vision.
However, this causes vision distortion in the lower part of the visual field at ground level
while walking. Since safe ambulation relies on the lower visual field to detect obstacles
(Marigold et al., 2008), and vision acts as a moderating factor for increased fall rates as
individuals age (Heasley et al., 2005), there is a need to investigate the connection
between MfLs, falls, and age.
Objective: This study hypothesized that when wearing MfLs, both young and
middle-aged individuals would experience a significant decrease in functional gait
performance when compared to wearing single lenses. In addition, non-experienced MfLs
wearers would both show similar within group gait performance decrement.
Methods: Sixteen 18-35 year olds and seven 45-60 year old novice MfL wearers
with no history of balance or gait impairments participated. A within-between subjects
repeated measures ANOVA and t-tests evaluated the effects of MfLs and age on toe
clearance, step force, and functional gait (the Dynamic Gait Index-Modified).
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Results: A statistically significant difference in toe clearance and DGI-m scores
were found for young and middle-aged individuals between lens conditions. Young
group: increase in toe clearance (t=4.801, p=.000) and decrease in DGI-m scores (t=-3.9,
p=.001); Middle-aged group: increase in toe clearance (t=3.230, p=.018) and decrease in
DGI-m (t=3.092, p=.021). No significant difference between groups was found (DGI-m
F=.020, p=.836, toe clearance F=.015, p=.905, and maximum force F=.463, p=.505). Due
to the multiple t- tests performed, an adjustment of a .0125 alpha was used for a
significance threshold.
Conclusion: MfLs appear to not only degrade visual performance, but also
degrades key components of gait performance. The results of this study provided
evidence that contributes to the validation of MfLs as a possible fall risk.
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PART I: THESIS OVERVIEW

2
Overview
This thesis is comprised of three parts: 1) the introduction to the thesis, 2) the
research manuscript, and 3) the appendices. Part 1) that you are reading consists of the
introduction to the thesis and provides an overview of the entire thesis and time line of
the study. Part 2) includes the research manuscript that contains sections such as literature
review and discussion of the results. The manuscript was written in a general manuscript
format in order to accommodate for different journals. Part 3) contains nine appendix
sections pertaining to the manuscript and overall thesis. These sections include research
proposal, supporting data, IRB approval documents, and equivalent text descriptions. All
writing is based on APA format.
Time Line of the Study
The following is a chronological summary of this study. Original documents were
submitted to the Institutional Review Board (IRB) in September, 2010. The protocol was
approved in October, 2010. After a pilot study, the research proposal was presented to the
committee of advisors. Committee members approved the research design and
hypotheses. Supplemental funding was provided through the Support of Undergraduate
Research Fellows and College of Health Science Research Grant.
The additional funding allowed participants to receive compensation upon
completing the study. Amendments were submitted to IRB due to changes in targeted
populations on the research flier. IRB also approved a protocol continuation on October
2011 which lasts until October 2012.

3
Summary of Changes
The proposal was adjusted based on feedback provided by the committee of
advisors. Research hypotheses were clarified and refined to increase understanding.
Committee members discussed using t-test to increase understanding of the statistics.
Changes were made after the data was collected. These include excluding the variable of
heel to step edge and decrease in the number of participants. The variable of heel to step
edge was excluded due to errors in data collection and processing. These errors made the
data enabled use. The remaining variables included modified dynamic gait index,
maximum force, and toe clearance. The number of participants included in the study was
sixteen 18-35-year-olds and seven 45-60-year-olds. Initial proposed recruitment included
twenty 18-35-year-olds and ten 45-60-year-olds. A smaller participant group was deemed
proficient as it demanded less resulted time to recruit and avoided difficulties recruiting
older individuals. All other protocol and procedures remained intact.
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PART II: RESEARCH MANUSCRIPT
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Abstract
Objective: The purpose of this study was to investigate the use of multifocal
lenses (MfLs) on both young and middle-aged individuals and how it affects their
functional gait.
Methods: Sixteen 18-35 year olds and seven 45-60 year old novice MfL wearers
with no history of balance or gait impairments. A within-between subjects repeated
measures design evaluated the effects of MfLs and age on toe clearance, step force, and
functional gait (the Dynamic Gait Index-Modified).
Results: A statistically significant difference in toe clearance and DGI-m scores
were found for young and middle-aged individuals when between lens conditions. Young
group: increase in toe clearance (t=4.801, p=.000) and decrease in DGI-m scores (t=-3.9,
p=.001); Middle-aged group: increase in toe clearance (t=3.230, p=.018) and decrease in
DGI-m (t=3.092, p=.021). No significant difference was found between groups (DGI-m
F=.020, p=.836, toe clearance F=.015, p=.905, and maximum force F=.463, p=.505).
Conclusion: The results of this study provided evidence that MfLs affect an
individual’s ability to perform normal gait patterns, and contributed to the validation that
MfLs should be considered a possible fall risk. This evidence eliminated the variable of
age as a factor in the changes in normal gait and provided more evidence that MfLs are
affecting gait patterns.
Introduction
Background on Multifocal Lenses
It is estimated that over 85% of adults over the age of 45 develop a condition
called presbyopia (Holden, Fricke, Ho, Wong, Schlenther, & Cronje, et al., 2008). This
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condition occurs with age and results in a loss of near distance vision. Reading glasses
are used as a functional adaptation for presbyopia. When an individual develops
presbyopia and also has a far distance vision impairment (myopia), reading glasses are
not sufficient to correct both impairments. Thus, many middle-aged and older adults wear
multifocal lenses (MfLs). Types of MfLs include lined bifocals, trifocals, and unlined
progressive lenses. MfLs are designed for both near and distance viewing. Progressive
lenses, the type most commonly worn today, attempt to make the transition from the
different lens fields smoother without having a bifocal line. This is achieved through
grinding two lenses into one seamless lens.
On the other hand, MfLs also cause visual challenges. In addition to a distortion at
the sides (Figure 1), MfLs, including progressive lenses, distort vision in the lower part of
the visual field at ground level while walking. Since safe ambulation relies on the lower
visual field to detect obstacles (Marigold & Patla, 2008), this distortion may lead to an
increase in falls and near falls when walking.
Figure 1: a) Progressive lens regions and b) view through progressive lens.

Falls and Vision
Falls are a major health problem with many correlated factors, including poor
vision. Falls result from intrinsic and extrinsic factors. Intrinsic factors include general
factors such as age and gender, physiological or functional factors, medical risk factors
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such as poor health, and the use of medications (Black & Wood, 2005). Extrinsic factors
include environmental risk factors such as inappropriate footwear and poor lighting
(Black & Wood, 2005). In 2008, 2.2 million nonfatal fall injuries among older adults
were treated in the emergency room and more than 581,000 of the 2.2 million were
hospitalized in the U.S. (Centers for Disease Control and Prevention, 2008).
Intrinsic factors that increase falls as individuals age include a decrease in
balance, strength, and overall health (Lord, Tiedemann, Chapman, Munro, Murray, &
Sherrington, 2005). As overall health decreases, there is an increase in the prevalence of
visual impairments. Many decreases in visual function are associated with falls including:
decreased contrast sensitivity, decreased visual acuity, impaired depth perception, and
visual field impairments. These visual impairments approximately double the fall risk
rate, making vision accountable for many falls (Lord, Smith, & Menant, 2010). Overall,
fall risk increases as visual impairments become more severe (Hardwood, 2001).
Two significant aspects of vision that contribute to an increase in falls include
contrast sensitivity and depth perception (Lord et al., 2010). Impairments in these are
linked affect changes in ambulation such as gait speed and variability, standing balance,
and toe clearance (Marigold & Patla, 2008; Black & Wood, 2005; Buckley, Harley, &
Elliott, 2008; Elliot & Chapman, 2010). MfL glasses are found to impair depth perception
and contrast sensitivity when detecting obstacles in the environment at critical distances
(Lord, 2006; Lord, Dayhew, & Howland, 2002). The impaired depth perception and
contrast sensitivity is caused by the lower reading portion of MfLs. Balance and stability
is also negatively affected by the impairment of depth perception and contrast sensitivity
(Lord, Sherrington, & Menz, 2000). Balance control is one of the main contributors to
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falls among aging individuals (National Institute of Health: Senior Health, 2009; Black &
Wood, 2005). Since adequate depth perception and contrast sensitivity are needed to
maintain balance and to detect and avoid hazards in an environment, MfLs can be
considered a potential fall risk (Lord & Dayhew, 2001; Menant, Smith, & Lord, 2008).
Falls and Multifocal Lenses
It is known that as individuals age they become increasingly prone to falls
because of an overall decrease in health (Lord et al., 2000; Lord et al., 2005). Because of
this fact, it is difficult to parse out how factors, such as MfLs, contribute to falls and near
falls. Research has found that MfL glasses affect middle-aged and older adults similarly,
except that the risk of falling is not as common in the middle-aged population. Middleaged, first time wearers experience significant decreases in depth perception, contrast
sensitivity, and functional mobility scores (Smith, Tomashek, Stalberger, & Rust, n.d.).
More importantly, depth perception, contrast sensitivity, and functional mobility did not
return to prior single lens levels of performance which indicates that adaptation may not
occur even six months after initially wearing MfLs (Smith, et al., n.d.). Comparing the
performance among different age groups will control for factors associated with age and
isolate the true effects of MfL glasses. Vision impairments increase with age which
makes vision a moderating role in increased fall rates (Heasley, Buckley, Scally, Twigg,
& Elliott, 2004). The need to investigate the connection between MfLs glasses and falls is
important for healthcare providers and fall prevention measures (Lord et al., 2002).
Observing the effects of MfLs on differing age groups may provide more evidence to
distinguish MfLs as a moderating variable between vision and gait impairment.
Hypotheses
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MfLs have been linked to degraded vision and gait changes. Falls also have been
connected to age and use of MfLs. However, no studies have examined age, MfLs, and
gait. As result, this study addressed three specific research hypotheses: 1) young nonexperienced MfL wearers decrease their functional gait performance when using MfL
glasses compared to single lenses, 2) middle-aged non-experienced MfL wearers
decrease their functional gait performance when using MfL glasses compared to single
lenses, and 3) the decrease in gait performances in both groups will be similar. These
results will show across three measures: toe clearance while walking up a step, force in
stepping down, and in the modified Dymanic Gait Index (DGI-m).
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Methods
Design
This study implemented an experimental mixed methods design and examined
MfL performance within-subject groups and between-subject groups. Two lens
conditions (single lenses and progressive MfLs) and two age groups (middle-aged and
young) served as the independent variables. Primary dependent variables included
maximum force on step down, toe clearance on step-up, and DGI-m scores. Maximum
force and toe clearance were measured using motion analysis, and the DGI-m was scored
by a trained rater.
Participants
Participants included sixteen 18-35 year olds and seven 45-60 year olds who did
not wear MfL glasses at the time of the study. Individuals who had mobility impairments
(such as slowness and poor balance), neurological diseases limiting daily activity, history
of osteoarthritis and osteoporosis, impaired stereopsis, visual diseases such as cataracts,
inner ear problems, history of vertigo or orthostasis, and individuals under the age of 18
years old were excluded from the study. Individuals with vision impairments that could
not corrected with contact lenses were excluded from the study. The eligibility
questionnaire included questions regarding age, gender, and physical condition (See
Appendix B). Individuals that met all criteria were considered for the study. Table 1
presents participant demographic information.
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Table 1: Mean and standard deviation demographic information for young and middleaged groups.
Young Group

Middle-Aged Group

mean

s.d.

mean

s.d.

Age

24.13

3.58

51.86

3.98

Gender (M/F)

(5/11)

Weight (lb)

142.53

34.68

157.03

29.51

Height (cm)

167.75

7.70

163.13

12.66

(3/4)

Measurement Instruments
Two methods were used to collect data and evaluate functional gait and
components of gait: 1) a motion analysis system, and 2) the DGI-m.
Motion analysis system. Ten Motion Analysis Raptor Cameras and three force
plates (AMTI) were used. The computer software used was Cortex 2.0.0 Motion
Analysis. This software was used to assess maximum force and toe clearance. Data
collected through Cortex 2.0.0 was labeled using motion analysis software. Labeled data
was then entered into MATLab and analyzed using coding. No filtering was performed
on the data and the sampling rate was 100 Hz.
Biomechanical measurements. Two biomechanical measurements were used in
this study. Toe clearance refers to the vertical height of the toe in relation to the step
when stepping onto a raised platform. Heasley et al. (2004) found that visual impairments
result in a higher toe clearance. Results from the Elliott & Chapman (2010) study
indicated that positive diopter blur caused an increase in toe clearance and negative
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diopter blur caused a decrease in toe clearance. In the current study, the progressive
lenses all had the same positive diopter or reading lens. The objective was to determine if
higher toe clearance was a physical result of the vision impairment caused by wearing
progressive lenses. Maximum force, the second biomechanical measure used, refers to
the maximum pressure when stepping down on a surface. Buckley, Heasley, Scally, &
Elliott (2004) hypothesized an increase in force on the landing foot when stepping down
in individuals that have a visual impairment. It was also found that participants used a
cautious approach when stepping down, which leads to ‘feeling’ or searching to find the
step (Buckley et al., 2004). This could have been the result of the participants being in an
elderly population. The variable of force could be an indicator of a visual impairment.
Dynamic Gait Index-Modified
The DGI assess was created to assess an individual’s ability to maintain balance
while walking in the presence of stimuli. The Dynamic Gait Index (DGI) has well
established reliability and validity for assessing functional mobility (Whitney, Hudak, &
Marchetti, 2000; Whitney, Wrisley, & Furman, 2003; Herman, Inbar-Borovsku, Brozgol,
Giladi, & Hausdorff, 2008; Jonsdottir & Cattaneo, 2007; McConvey & Bennett, 2005).
The DGI has been tested and validated on a variety of populations with balance
impairments; these impairments include vestibular disorders, multiple sclerosis, stroke,
Parkinson’s disease, and geriatrics (Rehabilitation Institute of Chicago, 2010). The eight
tasks of the DGI include gait on even surfaces, gait with changing speeds, both horizontal
and vertical head turns and gait, stepping over and around obstacles, gait with pivot turns,
and ascending and descending stairs. Scores are based on a 4-point scale. The highest
possible overall score is 24 points.
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This study implemented the use of the modified Dynamic Gait Index (DGI-m)
used by Smith et al. (n.d.). This contained an additional two tasks and a six point scale (05) to accommodate for ceiling effects in younger participants found in a previous thesis
study (Brayton, 2006). A zero indicated the individual could not walk 20 feet without
assistance and contained severe gait deviations or imbalance. A five indicated gait with a
normal speed, no evidence of imbalance, and a normal pattern. The highest possible score
was equivalent to 50, which indicated no gait impairments. The DGI-m consists of ten
walking tasks. The two additional tasks involved: stepping over a diagonal long box and
stepping on and off a platform. In this study the tenth task of the DGI-m was replaced
with a step/ramp to accommodate for the motion analysis creating the DGI-m2. The
highest possible score was equivalent to 45. Data collected from the rated DGI-m was
entered into a Microsoft Excel spreadsheet, which was then transferred into SPSS for
analysis.
Procedure
Institutional Review Board approval was obtained from the University of
Wisconsin-Milwaukee (UWM) prior to start the study. Participants were recruited
through fliers on the UWM campus and in the surrounding community. Interested
participants emailed the primary researcher and received a brief description of the study
and eligibility questions. After eligibility was confirmed, the researcher scheduled the
participant to come to the Gait and Biomechanical Lab. Participants were asked to wear
tight fitting clothes to ensure that markers stayed attached to skin or clothing.
Upon arrival at the lab, the participants, first read and signed the consent form.
The participants were then fitted with a safety harness connected to a trolley system to
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prevent injury if a fall were to occur. The researchers then applied 39 reflective markers
based on the Cleveland Clinic modified marker set directly to the skin and onto clothing.
Participants were attached to the harness pulley system and told to walk normally back
and forth across the lab to get comfortable walking with the harness and markers. While
the participant practiced, the researcher observed if their step down landed on the three
force plates. All instructions given to participants were script-based to minimize bias.
Also, the researcher did not instruct participants to step on the force plates so participants
were not drawn to think about their steps as normal gait was targeted. The participants
walked through 36 trials of a looped course that included 15 meters of walking in a
straight line. During this walk, they encountered either a ramp/step, a step/ramp, or flat
surface.
For the DGI-m tasks a trained rater scored participant’s gait on the DGI-m
walkway. Participants received specific instructions for each task. Following the
instructions, participants ambulated down the grid runway and performed the task. At the
end of the runway, participants walked to the ramp/step entry, forming a loop track. The
nine DGI-m tasks were performed four times or 36 trials; two while wearing +2.75
strength progressive lenses and two wearing blank single lenses. The order of lenses and
ramp/step was randomized. Additionally, a video camera was used to view the DGI-m
task for future reference. The step heights also randomized varied between three inches
and six inches. Single and progressive lens glasses were alternated every 18 trials. All
biomechanical data from the motion capture markers were collected by lab assistants.
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Data Analysis
SPSS Version 19.0 (SPSS, Inc., Chicago) was used to analyze data. Statistics
were calculated to determine the differences between and within age groups and lens
conditions.
Within subjects analyze was completed using a paired samples t-test to determine
the significance of wearing the different lenses within each population. Rare scores were
used when comparing the within data. Due to the multiple t- tests performed, an
adjustment of a .0125 alpha was used for a significance threshold. The between subjects
analysis was completed using a repeated measures Analysis of Variance (ANOVA).
Between subjects analysis determined the difference between lens conditions within the
populations and compared the difference among the two populations to determine if there
is a significant difference in switching lenses between groups. This was performed for
each dependent variable to investigate the change.
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Results
The sample included 23 participants (16 in the young and seven in the middleaged group). All participants completed the full trials and protocol. Overall, all
participants were healthy and demonstrated normal functional gait patterns prior to the
study.
Dynamic Gait Index-Modified
The first two research hypotheses pertained to the within subjects gait
performance. As hypothesized within the young adult group, results demonstrated a
significant decrease in DGI-m score (t=-3.900, p=.001) (p<.0125) between single to
progressive lenses. Decrease in DGI-m indicated a decrement in gait. The mean for
young adults when wearing progressive lenses was 43.1 and single lenses was 44.6. The
within middle-aged adult group was found to be not significant (t=3.092, p=.021)
between single to progressive lenses (Figure 2). The mean for middle-aged adults when
wearing progressive lenses was 43.2 and single lenses was 44.8.
The final hypothesis pertained to between subject performance. As hypothesized,
the difference between the within young and middle-aged groups revealed no significant
difference when comparing groups (F=.044, p=.836) (Figure 3). Table 2 displays the
results of the paired t-test among the two groups and lens conditions for DGI-m scores.
Table 2: Displays the DGI-m results of the paired t-test data for within subjects.
*= significant at .0125
Group
Within-Subject
Young Adult
Middle-aged

Mean (progressive
lenses)

Mean (single t-test
lenses)

p-value

43.1
43.2

44.6
44.8

.001*
.021

-3.9
3.1
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Figure 2: Bar graph depicting DGI-m means for
single and MfLs within group.

Figure 3: Bar graph depicting DGI-m means
for single and MfLs between groups.

Step Up Toe Clearance
As hypothesized, within the young adult group, results showed a significant
increase in toe clearance (t=4.801, p=.000) between single to progressive lenses. Within
the middle-aged adult group, results demonstrated no significance (t=3.230, p=.018)
between lenses (Figure 4). The mean for young adults when wearing progressive lenses
was 122.2 and single lenses was 93.8. The mean for middle-aged adults when wearing
progressive lenses was 138.5 and single lenses was 111.4. The difference between the
within young and middle-aged groups while switching lenses revealed no significant
difference when comparing groups (F=.015, p=.905) (Figure 5). Table 3 displays the
results of the paired t-test among the two groups and lens conditions for toe clearance.
Table 3: Displays the toe clearance results of the paired t-test data for within subjects.
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Mean (progressive
lenses)

Group
Within-Subject
Young Adult
Middle-aged

Mean (single
lenses)

122.2
93.8
138.5
111.4
*= significant at .0125

Figure 4: Bar graph depicting toe clearance means
for single and MfLs within groups.

t-test

p-value

4.801
3.230

.000*
.018

Figure 5: Bar graph depicting toe clearance
means for single and MfLs between groups.

Step Down Maximum Force
Within the young adult group, force results were found to be not significant
(t=1.645, p=.124) between single to progressive lenses. The within middle-aged adult
group was found to be not significant (t=.336, p=.751) between lenses (Figure 6). The
mean for young adults when wearing progressive lenses was 1.64 and single lenses was
1.57. The mean for middle-aged adults when wearing progressive lenses was 1.59 and
single lenses was 1.57. The difference between the within young and middle-aged groups
while switching lenses revealed no significant difference when comparing groups
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(F=.463, p=.505) (Figure 7). Table 4 displays the results of the paired t-test among the
two groups and lens conditions for force.
Table 4: Displays the force results of the paired t-test data for within subjects.
Group

Within-Subject
Young Adult
Middle-aged

Mean (progressive
lenses)

Mean
(single
lenses)

t-test

p-value

1.64
1.59

1.57
1.57

1.645
.336

.124
.751

Figure 6: Bar graph depicting force means
for single and MfLs within groups.

Figure 7: Bar graph depicting force means for
single and MfLs between groups.
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Discussion
There is a lack of clear understanding of how MfLs affect the gait of people of
different ages. The purpose of this study was to test the negative effects of the use of
MfLs among two age groups to determine if MfLs are a variable for fall risk. The results
of this study provided evidence that MfLs affect an individual’s ability to perform normal
gait patterns and contributed to the validation of MfLs as a possible fall risk. Because a
change in gait patterns was found in both age groups, it appears that MfLs are linked to a
decrement in normal gait pattern, regardless of age. Significantly lower DGI-m and
higher toe clearance scores suggested that the visual distortion in the lower visual field of
the lenses produced these gait abnormalities. Data distributions were examined through
histograms; see Appendix C.
Within Age Group Analysis
The significant difference between the single lens and MfLs trials for toe
clearance and DGI-m scores showed participants actively changing their gait to
accommodate for the distortion of their lower vision field. Data showed that individuals
experienced an increase in toe clearance when stepping up and decrease in functional gait
assessment scores. An increase in toe clearance indicated that, because of the distortion
of the step, individuals used a compensatory technique to find the location of the step.
Decrement in gait and compensatory actions changed the normal gait pattern of
individuals when MfLs were worn. Normal gait patterns changed when wearing the
MfLs. This changed gait pattern may result in an increased fall risk. The lack of a
significant difference between single and MfL trials for force indicated that participants
were not using a ‘feeling’ or protective method when detecting the floor upon stepping
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down, which was found in a previous study (Buckley et al., 2004). Additionally, this
outcome revealed that participants were not using increased force when stepping down.
This lack of increased force exhibits that the individuals understood the location of the
floor. The Buckley et al. (2004) study contained elderly participants with a mean age of
72.3 years. This difference in the age of participants may account for the increase in
force. Additionally, the participants in Buckley et al. (2004) study stepped from a
stationary position in comparison to the participants in this study performed a more
natural continuous gait which may contribute to a normal step down force.
Between Group Analysis
The data provided evidence that MfLs affect young and middle-aged individuals
similarly. This evidence eliminated the variable of age as a factor in the changes in
normal gait and provided more evidence that MfLs are affecting gait patterns. Both
groups showed the same overall change, but had different base scores for toe clearance
and the DGI-m. Different base scores are expected for the two groups due to the decrease
in health in the middle-aged group. Maximum force revealed the same overall change
indicating that MfLs do not affect force in both groups.
Limitations
Five limitations of this study are discussed. First, it was difficult to recruit middleaged individuals that did not wear distance lenses because of the limited population.
Second, the participants’ visual acuity had not been tested before performing the study
and visual acuity is based on participant report. Third, there may be a learning effect of
the DGI-m obstacles if the participants received the randomization of wearing the single
lens glasses first. Fourth, participants had difficulty adjusting to a comfortable gait
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pattern while wearing the harness and sensors. Some participants were concerned with
accidently detaching the sensors, which may have caused them to change their gait. Fifth,
the researcher, who was aware of the research hypotheses, preformed the rating of the
DGI-m, which may have biased the study results. Biomechanical variables are measured
using a computerized system which is free from bias. Protocol given to participants was
script-based which minimized bias when providing verbal instruction.

Future Research
Future research is needed in the area of MfLs effect on functional activities.
Further reliability and validity testing of the Dynamic Gait Index-modified in relation to
biomechanical measurements is required in order to show the need for a stronger
instrument for visual impairment detection. The relationship between MfLs and lengthof-wear time needs investigation in order to further understand lens adaptation.
Qualitative analysis of the comfort level of MfLs wearers would help researchers better
understand tasks that caused wearers personal discomfort and decreased function.
Continuing the research of MfLs and biomechanical variables will provide concrete
instrumentation measurement of the effects of the lenses. Effects of Mfls should continue
to be researched due to the large population of users.

Implications
The possible effects of MfLs has tremendous implications for a number of
professions including occupational therapists. “Occupational therapy is a profession that
specializes in reducing the impact of disabilities and promoting the highest level of
independence and quality of life in children and adults with all types of functional
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limitations” (AOTA, 2001). Occupational therapists show interest in the meaningful
activities and occupations that contribute to the client’s quality of life. Prevention
methods and interventions play a key role in occupational therapy practice. Identifying
possible risks, such as MfLs, will reduce the amount of injuries, and understanding the
possible risks of MfLs can lead to possible interventions. Interventions can take place
through patient education on the possible changes in gait and different strategies to use
for daily activities.
“Occupational therapy practitioners adjust the task or environment for the
individual’s particular needs and provide training or assistive technology to assist the
individual” (AOTA, 2001). Visual impairment ranks among the ten most prevalent
causes of disability in the United States, making it a significant area of practice for
occupational therapists (National Eye Institute, 2004). Occupational therapists need to
have the correct information in order to identify possible fall risks associated with visual
impairments related to MfLs. Increasing their knowledge of MfLs and how they affect
functional activities will allow occupational therapists to better address risks connected
with wearing MfLs.
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Conclusion
This study found that MfLs led to an increase in toe clearance and a decrease in
DGI-m score. This effect on functional gait could be found across all study populations.
The MfLs, however, had no measurable effect on stepping force. As a result of this
research a better understanding of MfLs and their usage among age ranges can be
determined. More research is needed to further knowledge and provide MfL users with
alternatives or interventions.
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Appendix A: Research Proposal
Introduction and Literature Review
Summary of the Problem
Literature has shown a link between visual impairments and an increased risk of
falling in older adults (Lord, 2002). Multifocal eyeglasses, which are designed for both
distance viewing and correcting presbyopia, distort vision in the lower part of the visual
field at ground level while walking. This distortion of vision may lead to an increase in
falls and near falls when walking. This project aims to provide clarification on the
relationship between multifocal eyeglasses (MfLs) and impairments to normal gait.
Specifically, this continuation of a previous pilot study investigates the functional gait
performance within and between groups of individuals while wearing multifocal and
single lens glasses. Functional gait performance will be compared within each age group
while wearing MfLs and single lens glasses. The within age group comparisons will
allow investigation of the reaction to initial use of multifocal lens glasses on gait
performance. The between groups analyses will allow investigation of age as variables
that may affect gait performance in ways that are known to increase the risk rate of falls.
Significance of Study
Fall prevention is an important public health issue that needs to be addressed by
all healthcare professionals because of the growing elderly population. Knowing specific
fall risk factors can provide healthcare providers with the information needed to prevent
falls. Investigating the use of MfLs and how they affect the gait of adults of all ages can
help identify and confirm MfLs as a moderating variable between vision and gait
impairment. Additionally, confirming evidence linking MfLs glasses and falls will lead to
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the creation of better interventions. Gaining knowledge about possible risk factors for
falls, such as MfLs use, will help occupational therapists who serve older populations and
individuals improve individuals’ vision and decrease fall risk.
Importance to Healthcare Professionals
Provision of the possible effects of MfLs has tremendous implications for a
number of professions including occupational therapists. “Occupational therapy is a
profession that specializes in reducing the impact of disabilities and promoting the
highest level of independence and quality of like in children and adults with all types of
functional limitations” (AOTA, 2012). Occupational therapists show interest in the
meaningful activities and occupations that contribute to the client’s quality of life.
Prevention methods and interventions play a key role in occupational therapy practice.
Identifying possible risks, such as MfLs, will reduce the amount of injuries and
understanding the possible risks of MfLs can lead to possible interventions. Possible
interventions can take place through patient education on the possible changes in gait and
different strategies that to use for daily activities.
“Occupational therapy practitioners adjust the task or environment for the
individual’s particular needs and provide training or assistive technology to assist the
individual” (AOTA, 2012). Visual impairment ranks among the ten most prevalent
causes of disability in the United States, making it a significant area of practice for
occupational therapist (National Eye Institute, 2004). Occupational therapists need to
have the correct information in order to identify a possible fall risks associated with
visual impairments related to MfLs. Increasing the knowledge of the role of MfLs and
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how they affect functional activities will allow occupational therapists to better address
risks connected with wearing MfLs.
Background
The following literature review describes the essentialness of mobility and the
role vision plays in mobility. This includes an overview of fall, balance, and vision
literature. Next, the implications of MfLs on mobility are discussed with a review of the
available literature. Following this is a discussion about the moderating variable of age.
Important definitions and a review of the literature ensues. Lastly is a discussion about
the proposed paradigm for the present study.
Scope of Falls Research
Falls are caused by numerous factors, both intrinsic and extrinsic. Intrinsic factors
include general factors such as age and gender, physiological or functional factors,
medical risk factors such as poor health, and the use of medications (Black, 2005).
Extrinsic factors include environmental risk factors such as inappropriate footwear and
poor lighting (Black, 2005). In 2009, 2.2 million nonfatal fall injuries among older adults
were treated in the emergency room and more than 581,000 of the 2.2 million were
hospitalized. In all ages and populations, the overall nonfatal fall number in 2009 was
8,782,664 (Centers for Disease Control and Prevention, 2010). In 2000, medical costs for
falls totaled $19 billion in the United States (Centers for Disease Control and Prevention,
2010). Unintentional falls have been the leading cause of nonfatal injuries treated in
hospital emergency departments (Center for Disease Control and Prevention, 2008).
Additionally, the risk rate for falls for individuals increases as they age. This is
significant because of the projected increase of older individuals over the next few
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decades (U.S. Census Bureau, 2010). As people age their sense of balance becomes less
acute; balance is one of the main contributor to falls (National Institute of Health: Senior
Health, 2009).
Link between Vision and Balance
Balance is primarily controlled by the inner ear (also known as the vestibular
system), information from the proprioceptive system, and the visual sensory system
(Redfern, 2001). Symptoms of balance disorders consist of dizziness, feeling of falling,
lightheadedness, and blurred vision (National Institutes of Health). The visual system
plays a vital role in maintaining balance when standing still and while moving (Wade,
1997). Because of this, visual impairments can greatly affect balance. The visual system
provides a visual reference of where the body is in space and the location of obstacles in
the environment surrounding the body. This information is then integrated with input
from vestibular balance and proprioceptive or somatosensory systems. A deficit in any of
these systems can cause an increased reliance on the other systems to remain balanced
(Black, 2005). As individuals age, reliance on visual information to maintain balance
increases (Pyykko, 1990). This has serious implications, as there is an increase in
prevalence of visual impairments with age. Middle-aged and older individuals are also
more dependent on vision than young individual for postural control (Harwood, 2001).
Impaired vision reduces postural stability, especially when paired with a disruption in the
vestibular and somatosensory systems, for young and older individuals (Lord, 1993;
Anand, 2002 & 2003). In addition, contrast sensitivity, depth perception, and stereopsis
are visual functions that are predictors of stability and reductions in these functions have
been found to reduce postural stability (Lord, 2000). The action of stepping can also
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account for a period of instability because of a narrow base support caused by a single
limb supporting all bodyweight (Buckley, 2004). This period of instability additional
factors that influence balance, such as vision, could cause a fall. Because age-related
changes in the visual system and disruptions in the vestibular or somatosensory systems
result in impaired balance control, impairment in balance control can lead to falls in older
individuals (Black, 2005).
Link between Vision Impairments and Falls
Impaired vision is an important and independent risk factor for falls (Lord, 2010).
Adequate depth perception and distant-edge contrast sensitivity are needed to maintain
balance and to detect and avoid hazards in an environment (Lord, 2001). Several visual
impairments are associated with falls; these include: contrast sensitivity, poor visual
acuity, self-reported poor vision, impaired depth perception, and visual field impairments.
These visual impairments approximately double the falls risk rate, making vision
accountable for half of all falls (Lord, 2010). Falls risk increases as visual impairments
become more severe (Hardwood, 2001). Because visual impairments increase with age,
falls also increase with age thus, there is a strong correlation of visual impairments and
falling as age increase (Heasley, 2005). Visual impairments such as poor visual acuity,
contrast sensitivity, depth perception, and visual field impairments all effect gait
(Marigold, 2008). Visual impairments have been linked to changes in gait speed and gait
variability, standing balance, toe clearance, and foot distance approaching a step, all of
which have been associated with an increase in the risk rate for falls (Black, 2005;
Buckley, 2008; Elliot, 2010). Impairment in visual functions, such as visual acuity,
contrast sensitivity, visual fields, and depth perception, are associated with falls or are

35
identified as risk factors for falling (Black, 2005). Visual impairments are a risk factor for
falls in individuals of all ages, but especially aging and middle-aged adults. Lord and
Dayhew (2001) found that fallers perform significantly worse on distance and near depth
perception when compared to non-fallers. It is also reported that low contrast visual
acuity nearly doubles the risk of falling (Lord, 2001). There are other factors that are
associated with falls and balance such as lighting, flooring, distractions, fatigue, and loud
noises that also need to be taken into consideration (Lord, 2000).
Contribution of Multifocal Lens Glasses
It is estimated that over 85% of all adults over the age of 45 will develop
presbyopia (Holden, 2008). This condition develops with age and causes loss of near
distance viewing. Reading glasses are used to correct presbyopia. When an individual
develops presbyopia and has a far distance viewing impairment, also known as myopia,
reading glasses are not sufficient to correct both impairments. Because of this dilemma,
MfLs, which include lined bifocals, trifocals, and progressive lenses, are often prescribed.
In lined bifocals, the lower lens corrects near distance vision and the upper lens acts as
regular distance corrective lenses. These sections are clearly delineated, as the reading
portion is “added” to the regular distance viewing lens. In an attempt to make the
transitions from the different lens fields smoother without having a bifocal line,
progressive lenses have distortion on the sides of the lens caused by grinding (Figure 1).
Progressive lenses, which are common today, can potentially cause more problems
because of the additional region for middle distance viewing vision (Figure 2). This
distortion results in loss of visual acuity. Progressive lens users experience a warping
effect when turning their head, which can lead to an experience of discomfort and
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dizziness. MfLs glasses also impair depth perception and edge-contrast sensitivity at
critical distances for detecting obstacles in the environment (Lord, 2006 & 2002). The
impaired depth perception and edge-contrast sensitivity is caused by the lower portion of
multifocal lenses. Safe ambulation relies on the lower visual field to detect obstacles
(Marigold, 2008). Additionally, impairments in depth perception and edge-contrast
sensitivity may cause negative changes in balance (Lord, 2000). Thus, the various effects
of MfLs could be a factor that cause increased risk rates for falls among different ages.

Figure 1: View through progressive lens Figure 2: Progressive lens regions
Multifocal lens glasses and older adults. Individuals over the age of 45 are at
risk of developing presbyopia as they age (National Eye Institute, 2010). Because of this
condition, many older adults wear MfLs glasses. In 2005, about 1.8 million individuals
aged 65 and older were treated for nonfatal falls (Center for Disease Control and
Prevention). The relationship between vision and falls has generally focused on older
adults who have a decrease in corrective balance, limb sensation, strength, and overall
health (Lord, 2005). Physical impairments caused by aging increases the possible risk
factor of MfLs glasses. It is found in older adults that the near distance lens portion
impairs distance contrast sensitivity and depth perception in the lower visual field (Lord,
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2006). This impairment causes a decrease in the ability to detect ground level objects.
The add region of MfLs glasses cause an increase in toe clearance variability (Elliott,
2010). The risk of falling when using stairs may be exacerbated due to inaccurate visual
information regarding the exact location of the step caused by blurring (Johnson, 2007).
Lord (2002), anecdotally states that it appears there is an increase risk of tripping or
falling strongly associated with stairs.
Multifocal lens glasses and middle-aged adults. MfLs glasses have a similar
effect on middle-aged adults as older adults, except the risk of falling is not as common
in the middle-aged population. In a previous study it was found that participants who
wore new MfLs for the first time experienced significantly decreased depth perception,
contrast edge sensitivity, and functional mobility scores (Smith, R.O., Tomashek, D.,
Stalberger, K., & Rust, K.). Over 6 months, there was a gradual adaptation in depth
perception and contrast edge sensitivity but results never reached initial single lens
scores. It was found that functional mobility was effected with new MfLs when compared
to single lenses and mobility did not significantly change in the first six months of
wearing MfLs. Although falling is not common in this population, the impairments
caused by MfLs are identified as risk factors for falling. Most importantly it was found
that depth perception, contrast edge sensitivity, and functional mobility did not return to
the levels of performance when wearing single lenses, which indicates that adaptation,
may not happen as quickly as 6 months (Smith, R.O., Tomashek, D., Stalberger, K., &
Rust, K.). The adaptation of MfLs needs further investigation to understand fully.
Investigating age. The reason for investigating age is to show the direct effect of
MfLs on gait. Young individuals that wear MfLs will show that the lenses are the cause
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of disturbances in gait, thus eliminating other factors associated with aging. As
individuals age they become increasingly prone to falls (Lord, 2000). This is due to
decrease in balance, strength, and overall health (Lord, 2005). Analyzing the performance
between single and MfLs will show the effect of the lenses on gait in young and middleaged groups. The analysis of age performance the researchers can then compare the
performance between ages. Comparing the performance among ages will control for the
factors associated with age and show the effect of MfLs glasses instead of showing the
effect of the aging process.
Influence of experience. Experience refers to the length of time (approximately
six months) an individual has been wearing MfLs glasses. It is thought that experienced
multifocal lens wearers undergo an adaptation phase. This adaptation phase consists of
adjusting the visual system and body to the distortion of the lower portion of the visual
field. A common perception is individuals who have visual impairments adjust their
movements to adapt for the visual distortion (Buckley, 2008). Also, literature
hypothesizes that experienced individuals mentally normalize themselves to performing
with a cautious gait. When an individual cannot see a step or obstacle, they adapt a more
cautious gait pattern, which includes overcompensations, such as lifting their foot higher
when negotiating a step, longer single lens stance, and greater head flexion. This type of
gait has been found to be dangerous and may increase fall risk (Heasley, 2004; Buckley,
2008). Individuals that wear MfLs glasses for the first time exhibit the same cautious gait
(Buckley, 2008). This type of gait may be an indication that experienced multifocal
wearers never fully adapt to the glasses. Rather, they adapt a cautious gait style to
compensate. Initial MfLs wearers show a significant decrease in depth perception,
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contrast edge sensitivity, and functional mobility. Most importantly it was found that
depth perception, contrast edge sensitivity, and functional mobility did not return to the
levels of performance when wearing single lenses, which indicates that adaptation, may
not happen as quickly as 6 months in middle-aged individuals (Smith, R.O., Tomashek,
D., Stalberger, K., & Rust, K.).

Multifocal Overall Research Needs
Past research in the area of MfLs glasses points to five current needs for
investigation of vision related falls. These include further reliability and validity testing
of the Dynamic Gait Index-modified in relation to biomechanical measurements will
show the need for a stronger instrument for visual impairment detection and investigating
the relationship between middle-aged and young novice MfLs wearers to understand the
role of age when wearing MfLs.
This proposed study targets the issue of age acting as a mediating variable for gait
impairments in young and middle-aged novice MfLs wearers. Investigating age will
control for the factors associated with age such as poor balance and decreased strength
(Lord, 2005). This control will show the effect of the MfLs glasses rather than age
effects.
Hypotheses
The research hypotheses are as follows:
1. Young non-experienced MfLs wearers will show a decreased functional gait
performance when using MfLs glasses compared to single lenses.
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2. Middle-aged non-experienced MfLs wearers will show a decreased functional gait
performance when using MfLs glasses compared to single lenses.
3. Given groups of individuals (young non-experienced MfLs wearers and middleaged non-experienced MfLs wearers) both will show the same within group gait
performance difference when using MfLs glasses compared to single lenses when
using two biomechanical instruments and the gait index. Between group gait
performance will have different base scores but the same overall change.

a) When walking up a step, young non-experienced MfLs wearers and
middle-aged non-experienced MfLs wearers will show a similar within
group increase toe clearance between single and MfLs glasses conditions.
b) When stepping down, young non-experienced MfLs wearers and middleaged non-experienced MfLs wearers will show a similar within group
normal force increase between single and MfLs glasses conditions.
c) When performing the DGI-m, young non-experienced MfLs wearers and
middle-aged non-experienced MfLs wearers will show a similar within
group gait performance score decrease between single and MfLs glasses
conditions.
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Research Design

Three
biomechanical
measurements
and DGI-m
Group 1

Group 1

Young Novice
Multifocal
Wearers

Young Novice
Single Lens
Wearers

Hypothesis

Middle-aged
Novice
Multifocal
Wearers

Middle-aged
Novice Single
Lens Wearers

Group 2

Group 2
Three
biomechanical
measurements
and DGI-m

Figure 3: This figure represents the hypothesis as a within and between group analysis of
middle-aged and young novice multifocal and single lens wearers. All participants will be
measured using three biomechanical variables and the DGI-m.
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Methods
Overall Design
This study implements an experimental simple mixed methods design. This
design consists of both within-subjects and between-subjects variables. This design is
being used because it allows the researcher to test different populations under different
variables such as single and MfLs glasses. As this study examines two independent
variables, it is considered a simple mixed design (Meyers, 2006). Figure 4 represents the
different groups in the study and the characteristics of each group.

Group

Age

Experience

Glasses

One

Young

Novice

Multifocals/
Single

Two

Middle-aged

Novice

Multifocals/
Single

Figure 4: Table of participant group demographics.
Participants
The study is being conducted at the Gait and Biodynamics Laboratory at the
University Services and Research (USR) building on the UWM campus. The study takes
approximately 1.5 hours over the course of one day for each participant. Participants sign
an informed consent document to participate in the study per the protocol approved by
the University of Wisconsin–Milwaukee Institutional Review Board for human subject
research. The recruitment process is being done through flyers around campus and in the
surrounding community.

43
Thirty participants will be recruited to participate. They will divide into two
groups. Group one will consist of 20 young individuals and Group 2 will consist of ten
middle-aged individuals. This research expands on 6 young subjects recruited by the
researcher for a previous pilot study. The 6 previous subjects will be included in this
study.

Inclusion and exclusion criteria. Qualifying participants must be healthy
individuals between the ages of 18-35 (Group One Younger) or 45-60 (Group Two
Middle-aged). Individuals who have mobility impairments such as slowness and poor
balance, neurological diseases limiting daily activity, history of osteoarthritis and
osteoporosis, impaired stereopsis, visual diseases such as cataracts, inner ear problems,
history of vertigo or orthostasis, and individuals under the age of 18 years old will be
excluded from the study. Individuals who have vision impairments that are not corrected
with contact lenses will be excluded from the study. The progressive lenses will be nonprescription on the top, and cannot be worn over other glasses, only those with vision
corrected with contact lenses will be eligible.
Eligibility questionnaire includes:
1. What is your age?
2. Are you male or female?
3. Can you walk without any assistive devices?
4. Do you typically wear eye glasses?
a. Do you wear bifocal or progressive lens glasses?
b. Do you have contact lens glasses that you can wear during the testing session
that correct your vision?
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5. Are you currently recovering from or do you currently suffer from any
musculoskeletal disorders that affect your ability to walk such as: broken bones,
strains sprains or genetic disorders?
6. Are you currently pregnant, think you could be pregnant or trying to become
pregnant?
7. Do you have osteoporosis or osteoarthritis?
8. Do you currently have any sensory disorders that affect your balance or are you
taking any medications that might affect your balance?
9. Do you weigh over 300 pounds?

Independent and Dependent Variables
Independent variables. The independent variables consist of the two lens
conditions; single lens glasses and MfLs glasses. The single lens glasses are blank nonprescription lenses which are worn by the young and middle-aged novice participants.
The young and middle-aged novice participants wear progressive lenses with an add
prescription of +2.75 for the multifocal lenses. Progressive lenses with +2.75 prescription
are used because of popularity of the lenses and +2.75 is a moderate level prescription.
Age is also an independent variable. The age of the young participants is 18-35 years old
and the age of the middle-aged participants is 45-60 years old. The different ages of the
participants will be analyzed in the results.
Dependent variables. The dependent variables include maximum normal force,
heel to step edge, toe clearance, and DGI-m scores. Normal force refers to the maximum
pressure when stepping down on the floor. This is measured by the foot stepping down
onto a force plate. In an article by Buckley et al. (2004), it was hypothesized that there
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will be an increase in bodyweight on the landing foot when stepping down in individuals
that have a visual impairment. It was also found that participants were using a cautious
approach when stepping down, which led to ‘feeling’ to find the step (Buckley, 2004).
This could have been the result of the participants being an elderly population. Heel to
step edge on the stair refers to the position of the first heel contact in relation to the edge
of the step. Research has shown that individuals with visual impairments step closer to
the edge of the step or slightly off the step (Elliott, 2010; Johnson, 2008). Toe clearance
refers to the vertical height of the toe in relation to the step. Heasley et al 2004 found that
visual impairments result in a higher toe clearance. Results from the Elliott et al 2010
study indicate that positive diopter blur causes an increase in toe clearance and negative
diopter blur causes a decrease in toe clearance. The progressive lenses used in this study
all have the same positive diopters. This variable will be measured to analysis which
theory applies to multifocal wearers. DMI-m scores illustrate the gait performance of the
participants.

Age
Group 1:
Young
Novice
Wearers
Group 2:
Middleaged
Novice
Wearers

Variables
Independent
Variables

18 Trials
Single Lens Glasses
(randomized)
•

Dynamic
Gait Index
Modified

•

Normal Force

•

Normal Force

•

Toe
Clearance

•

Toe
Clearance

18-35
Dependent
Variables
45-60

18 Trials
Multifocal Lens
Glasses +2.75
(randomized)
• Dynamic
Gait Index
Modified
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Instrumentation
Two data collection instruments will be used to observe the changes that may
occur when wearing MfLs: 1) The modified version of the Dynamic Gait Index-modified
(DGI-m) and 2) biomechanical variables recorded using a motion capture system as
subjects move through a walking course.
Dynamic Gait Index-modified. The DGI has well established reliability and
validity for testing functional mobility for many different populations (Whitney, S.L.,
2000 & 2003; Herman, T., 2008; Jonsdottir, J., 2007; McConvey, J., 2005). This study
will use the modified DGI version used by Stalberger (unpublished). This contains an
additional two tasks and a six point scale to accommodate for ceiling effects in younger
participants found in a previous thesis study (Brayton, unpublished). The DGI-m consists
of nine walking tasks. These include: walking at normal speed, changing speeds, turning
the head horizontally while walking, turning the head vertically, walking then pivoting,
stepping over a shoebox and diagonal long box, stepping around cones, and stepping on
and off a platform. Figure 5 illustrates the shoebox task. The original DGI contains a
tenth task of a multiple up and down steps. This task is replaced with a step/ramp to
accommodate for the motion analysis. All nine tasks are scored by a trained rater. Scoring
is based on a zero through five scale. A zero indicates the individual could not walk 20
feet without assistance and contained severe gait deviations or imbalance. A five
indicates gait was a good speed, no evidence of imbalance, and a normal pattern. A
perfect score is equivalent to 45.
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Figure 5: Participant performing Task 6 of the DGI; Stepping over an obstacle

Biomechanical measurements. Biomechanical variables will be collected using
motion capture analysis (MCA) by applying 39 motion capture markers on participant’s
joint landmarks. The markers are placed in a Cleveland Clinic modified marker set.
Motion capture markers are placed on the extremities, head, back, and pelvis (Figure 6).
MCA measures participant’s joint flexion and extension of the lower extremities to detect
changes in gait. MCA will be analyzed using the Cortex 2.0.0 software. The
biomechanical variables that are being collected consist of normal force, lead heel
position on the stair, and toe clearance.
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Figure 6: Picture of the motion capture sensors on the lower extremities.
Procedure
Participants are recruited through fliers on the UWM campus and in the
surrounding community. Interested participants email the researcher and receive a brief
description of the study and eligibility questions. After eligibility is confirmed, the
researcher schedules the participant to come to the University Services and Research
(USR) building. Participants are asked to wear tight fitting clothes to ensure markers stay
attached to skin or clothing. Upon arrival at the lab, the participant first signs the consent
form. The participant is then fitted with a safety harness connected to a trolley system
that prevents a participant who falls from hitting the ground. The researchers then apply
36 reflective markers directly to the skin and onto clothing.
Participants are then attached to the harness pulley system and told to walk
normally back and forth across the lab to get comfortable walking with the harness and
markers. While the participant is practicing, the researcher observes if their step down
lands on the force plates. After the appropriate amount of practice walks the participant is
ready to begin the experiment. The participant walks through 36 trials of a looped course.
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The loop course includes 15 meters of walking in a straight line. During this walk, they
encounter a ramp/step, step/ramp, or flat surface. This is then followed by a DGI-m task
(Figure 7).

Figure 7: Order of the DGI-m tasks.
A trained rater scores the participant as they walk down the DGI-m walkway.
Additionally, a video camera is used to view the DGI-m task for future reference. The
order of the ramp and step is randomized. The step heights vary between 3 inches and 6
inches. Single and progressive lens glasses were alternated every 18 trials. The order of
single and progressive lenses is randomized. All biomechanical data from the motion
capture markers is collected by Gait and Biomechanical Lab researchers. After
completion of the 36 loop trials, the participant is asked to remove all markers. Lastly, the
participant fills out a subjective, Likert-like survey pertaining to comfort when wearing
the multifocal lenses when completing tasks of the DGI-m. The researcher then obtains
information regarding the participant receiving their compensation of a $30 check.
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Data Analysis
This study implements an experimental simple mixed methods design. This
method is being used to measure within differences when switching from single lens
glasses to MfLs and differences between the two groups. Data collected through Cortex
2.0.0. will be labeled using motion analysis software. Labeled data will then be entered
into MATLab and analyzed using coding. Data collected from the rated DGI-m will be
entered into an Excel spreadsheet, which will then be transferred into SPSS for analysis.
A repeated measures multivariate ANOVA will be conducted for data analysis. A
MANOVA will allow the researcher to perform a between and within comparison among
the middle-aged and young participants. The independent variables include: The glasses
conditions (i.e., MfLs glasses vs. single lenses), and age (young vs. old). The dependent
variables include: normal force, lead heel position, toe clearance, and DGI-m scores.
Within-subjects comparison means the subjects act as their own control. The change in
the subjects’ performance is compared to the subjects’ initial base line (Portney, L.G.,
2009). The within group variable is gait performance with MfLs versus single lens
glasses. The difference in the performance of the individuals while wearing the different
lenses will provide the amount of change in gait. Between-subjects comparison means the
subjects are assigned to independent groups and the subjects in one group are compared
to the other group (Portney, L.G., 2009). The between group variables for this study are
middle-aged and young participants. The difference found between the different lens
conditions within each group is then compared between age groups. The outcome
measures will differ for the two groups because of age but the overall measurement will
be the same.
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Within-Subjects
Variables

Single Lens  MfLs

Between-Subjects
Middle-aged  Young

DGI-m

X-X

M1 - M2

Toe Clearance

X-X

M1 - M2

Normal Force

X-X

M1 - M2

Figure 12: Represents within and between subjects difference.
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Anticipated Results
Data is collected using Cortex 2.0.0 and interpreted into biomechanical variables
through MATLab. The graphs below show the expected results when switching between
single lens glasses and MfLs for middle-aged and young novice participants.

Figure 8: When performing the DGI-m young non-experienced MfLs wearers and
middle-aged non-experienced MfLs wearers will show a similar within group gait
performance score decrease between single and MfLs glasses conditions. Lower DGI-m
score indicates gait impairment.
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Figure 9: This figure represents walking up a step young non-experienced MfLs wearers
and middle-aged non-experienced MfLs wearers will show a similar within group
reduced step edge to heel placement length performance between single and MfLs glasses
conditions. Lower edge to heel length indicates gait impairment.

Figure 10: This figure represents stepping down young non-experienced MfLs wearers
and middle-aged non-experienced MfLs wearers will show a similar within group normal
force increase between single and MfLs glasses conditions. An increase in normal force
indicates gait impairment.
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Figure 11: This figure represents walking up a step young non-experienced MfLs wearers
and middle-aged non-experienced MfLs wearers will show a similar within group
increase toe clearance between single and MfLs glasses conditions. Higher toe clearance
indicates a cautious gait.
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Discussion
Limitations
Five limitations of this study are discussed. First, it may be difficult to recruit
middle-aged individuals that do not wear distance lenses because of the limited
population. Second, researchers suggested recruiting ten middle-aged novice MfLs
wearers, which may be underpowered. Third, the participant’s visual acuity has not been
tested before performing the study and visual acuity is based on participant report.
Fourth, there may be a learning effect of the DGI-m obstacles if the participants receive
the randomization of wearing the single lens glasses first then the MfLs glasses. Fifth,
participants can have a difficult time adjusting to their comfortable gait while wearing the
harness and sensors. Additionally, some participants are concerned in regards to
accidently detaching the sensors, which may cause them to change their gait.
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Appendix B: Eligibility Questionnaire

Thank you for your interest. The purpose of this study is to determine the effects of
bifocal glasses on walking balance. During this study, you will be asked to walk across a
course that includes different tasks including: walking on ramps, and stepping up and
down from stairs. While you are walking, we will record your motion, forces and muscle
activity using several different sensors. In addition, we will video record you walking but
you have the option to refuse the use of this videotaping without an effect on your
eligibility. Testing will take 1.5 hours over 1 day. Testing will take place at the
University Services Research Building on North 1st Street about 1.5 miles from the main
University of Wisconsin-Milwaukee campus.
You will have to answer some questions to check eligibility. All answers will be kept
confidential.
A) What is your age? Answer: _______
B) Are you male or female? Answer: _______
B) Can you walk without any assistive devices? Answer: ___________
C1) Do you typically wear eye glasses? Reading or Distance? Answer: _________
C2) If answer is yes, then ask: Do you wear bifocal or progressive lens glasses? Answer:
______
C3) If answer to C2 is yes: Do you also have a set of single lens glasses? Answer:
_______
C4) If answer to C2 is no, then ask: Do you have contact lens glasses that you can wear
during the testing session that correct your vision?
Answer: _________
D) Are you currently recovering from or do you currently suffer from any
musculoskeletal disorders that affect your ability to walk such as: broken bones, strains
sprains or genetic disorders?
Answer: __________
E) If subject is female: Are you currently pregnant, think you could be pregnant or trying
to become pregnant? Answer: __________
F) Do you have osteoporosis or osteoarthritis? Answer: __________ (Modification for
item 1)
G) Do you currently have any sensory disorders that affect your balance or are you taking
any medications that might affect your balance? These include: bilateral vestibular
disorder and peripheral neuropathy?
Answer: ___________
H) Do you weigh over 300 pounds? Answer: __________

63
Appendix C: Supporting Data and Graphs

Figure 1
Figure 2

Figure 3

Figure 4
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Figure 5

Figure 6

Figure 6

Figure 7
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Figure 8

Figure 10

Figure 9

Figure 11
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Figure 12

Figure 14

Figure 13

Figure 15
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Figure 16

Figure 17
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Appendix D: Study Flyer
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Appendix E: Research Study Script
Role of Bifocal Lens Glasses on Walking Balance IRB 11.069 Directions Script
Welcome participants:
Make sure the participants have appropriate clothing and footwear; show them where the
changing room is located.
Introduce the study:
“For this study we will be performing a number of walking trials. Each trial will consist
of walking through a specific route. To begin, we will be attaching a safety harness, to
protect you from any unexpected trips or falls. First, we will help you to put on the
harness, which you will wear through the entire test. We will then attach sensors for our
motion capture and EMG equipment. You will also have these on for the entire testing
period.”
“As we begin each trial, we will attach the harness to a hook, We will give you a brief
set of instructions, then have you walk at your natural pace either up a step or ramp.
When the experimenter says stop, stop and we will unhook the harness. You will then turn
to your left and walk to the next testing area. The next test consists of you walking down a
walkway. I will explain different tasks, such as turning your head, or walking at different
speeds to perform while walking down the walkway. After finishing the walkway tasks, I
will say OK, and you will turn left back to the starting point to be reharnessed. Any
questions?”
(NOTE: We should probably go over the tasks of the DGI-m with the participants at this
time, so that the directions are clear and quick when they do the actual task.)
Trial set-up:
Apply the EMG markers to the participant. (Explain that the experimenter will touch
them to apply the markers and shave hair in EMG area so they stick better.)
Help the participant into the harness. Explain to them that the harness should be tight
fitting but comfortable.
Apply the motion capture markers to the participant. (Explain that the experimenter will
touch them to apply the markers and will come in close contact with them.)
Test the motion capture equipment. “Now we are going to test the markers we’ve just
placed on you. Stand facing the wall with your arms out to the side and feet hip width
apart, like this (demonstrate). When I say go, start moving and bending your shoulders,
then wrists, then elbows, then knees and ankles, and lastly hips.” (Demonstrate
movement for participant) (Wait until experimenter at computer say go) “Ok, start.” “
OK, stop.”
Trials:
Show the participant where to start (on the tape mark).
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“When I say start, start walking. Always begin with your left foot (Point to which foot
you would like them to start with). Walk at your natural pace. When I say stop, stop
walking. Do you have any questions?”
“Let me know if you are having any problems, or feeling uncomfortable, and we will
stop at anytime during the testing. We’ll give you a break or two to drink water or use
the facilities.”
“Start.”
Participant walks over ramp/step to the end.
“Stop.”
Unhook the harness, and have the participant proceed to the DGI-m walkway.
Explain the DGI task. (See DGI instructions).
Participant does the DGI task.
“Stop. OK, turn to the left, and we’ll reharness you for the next trial.”
Next trial:
“Ok, we’re going to do the same task as before. Do you have any questions?”
Every 3-4 trials:
“Remember to start with your left foot, and to walk at your natural pace.”
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Appendix F: Dymanic Gait Index- modified Instructions
DGI-M Protocol and Directions

Introduction:
“I will be asking you to perform various tasks such as stepping over and walking around
an object while walking on the mat. For each task you will walk to the other end of the
grid. IF I say “OK”, walk to the next part of the experiment. Please listen carefully to
the instructions. There are 9 tasks total. These tasks include, walking at your normal
speed, changing speeds, turning your head to the sides while walking, tilting your head
up or down while walking, stopping and turning in the middle, and stepping over or
around obstacles.

“I will give you detailed information before each set of tasks.

Do you have any questions?”
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1. Gait level surface _____
change speed

next task:

Instructions:
“When I tell you to begin, walk at your normal speed from here to the end of the
grid.”
[Therapist walks to side]

“Begin walking at your normal speed now.”

Grading: Mark the lowest category that applies.
(5) Normal: Walks 20 feet: Good speed, no evidence of imbalance, normal gait
pattern.
(4) Walks 20 feet: Good speed, either slight imbalance or steps out of gait pattern.
(3) Mild impairment: Walks 20 feet, normal gait pattern with slower speed.
(2) Moderate impairment: Walks 20 feet,
•

slow speed, AND

•

evidence of mild imbalance and/or abnormal gait pattern.

(1) Walks 20 feet,
•

slow speed, AND

•

abnormal gait pattern, evidence of moderate imbalance.

(0) Severe impairment: Cannot walk 20 feet without assistance, severe gait
deviations, or imbalance.
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2. Change in gait speed _____

next task:

Horizontal head turns
Instructions:
“When I tell you to begin, walk at your normal speed towards the end of the grid
[for 5 feet]. When I say "quick", walk as fast as you can [for 5 feet] until I say
"slow", then walk as slowly as you can [for 5 feet].”
[Therapist walks to side]

“Begin walking at your normal speed now … Quick … Slow … Normal speed.”

Grading: Mark the lowest category that applies.
(5) Normal: Able to smoothly change walking speed without loss of balance or gait
deviation. Shows a significant difference in walking speeds between normal, fast,
and slow speeds.
(4) Able to change speed, but demonstrates either slight imbalance or slight step out
of gait pattern.
(3) Mild impairment: Is able to change speed but demonstrates mild gait deviations,
or no gait deviations but unable to achieve a significant change in velocity.
(2) Changes speed with a moderate loss of balance and is able to continue walking.
(1) Moderate impairment: Makes only minor adjustments to walking speed, or
accomplishes a change in speed with significant gait deviations, or changes speed
but demonstrates significant loss of balance.
(0) Severe impairment: Cannot change speeds, or loses balance and has to reach for
wall or be caught.
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3. Gait with horizontal head turns _____

next task: vertical

head turns
Instructions:

“When I tell you to begin, walk at your normal speed from here to the end of the
grid, following my instructions as you walk. When I tell you to look right [5
feet], keep walking straight but turn your head to the right. Keep your head
turned to the right until I tell you, “look left” [5 feet], then keep walking straight
and turn your head to the left. Keep your head to the left until I tell you, “look
straight” [5 feet], then keep walking straight, but return your head to the center.”
[Therapist walks to side]

“Begin walking at your normal speed now… Look right… Look left … Look
straight.”

Grading: Mark the lowest category that applies.
(5) Normal: Performs head turns smoothly with no change in gait.
(4) Normal speed, performs head turns smoothly with evidence of either slight
imbalance or slight step out of gait pattern.
(3) Mild impairment: Performs head turns smoothly with slight change in gait
velocity.
(2) Performs head turns smoothly with evidence of moderate loss of balance.
(1) Moderate impairment: Performs head turns with moderate change in gait velocity,
slows down, staggers but recovers, can continue to walk.
(0) Severe impairment: Performs task with severe disruption of gait, i.e., staggers
outside 15-inch path, loses balance, stops, reaches for wall.
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4. Gait with vertical head turns _____

next

task: Pivot turn
Instructions:
“When I tell you to begin, walk at your normal speed from here to the end of the
grid, following my instructions as you walk. When I tell you to “look up,” keep
walking straight, but tip your head and look up towards the ceiling. Keep looking
up until I tell you, “look down.”. Keep looking down until I tell you, “look
straight,” then keep walking straight, but return your head to the center.”
[Therapist walks to side]

“Begin walking at your normal speed now … Look up … Look down … Look
straight.”
Grading: Mark the lowest category that applies.
(5) Normal: Performs head turns with no change in gait.
(4) Performs head turns with evidence of either slight imbalance or slight step out of
gait pattern.
(3) Mild impairment: Performs task with slight change in gait velocity
(2) Performs head turns with evidence of moderate loss of balance.
(1) Moderate impairment: Performs task with moderate change in gait velocity, slows
down, staggers but recovers, can continue to walk.
(0) Severe impairment: Performs task with severe disruption of gait, i.e., staggers
outside 15 inch path, loses balance, stops, reaches for wall.
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5. Gait and pivot turn _____

next task: step over

shoebox
Instructions:

“When I tell you to begin, begin walking at your normal speed towards the end of
the grid. When I tell you, “half-turn and stop,” turn half way around as quickly as
you can to face the opposite direction and stop. I will then ask you to turn back to
the original direction, and walk to the end.”

[Therapist walks to side]

“Begin walking at your normal speed now … half-turn and stop, turn around
again and continue walking to the end.”

Grading: Mark the lowest category that applies.
(5) Normal: Pivot-turns safely within 3 seconds and stops quickly with no loss of
balance.
(4) Pivot-turns safely within 3 seconds and stops quickly with a slight loss of balance.
(3) Mild impairment: Pivot-turns safely in more than 3 seconds and stops with no loss
of balance.
(2) Pivot turns with a moderate loss of balance
(1) Moderate impairment: Turns slowly, requires verbal cueing, requires several small
steps to catch balance following turn and stop.
(0) Severe impairment: Cannot turn safely; requires assistance to turn and stop.
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6. Step over obstacle (shoebox) _____

next task: step around

cones
Instructions:

“When I tell you to begin, walk at your normal speed from here to the end of the
grid and stop. When you come to the shoebox, step over it, not around it, and
keep walking.”

[Therapist walks to side]
“Begin walking at your normal speed now by stepping over the shoebox, not
around it.”

Grading: Mark the lowest category that applies.
(5) Normal: Is able to step over box without changing gait speed; no evidence of
imbalance.
(4) Steps over box with slight imbalance/step out of gait pattern or unable to clear
box completely.
(3) Mild impairment: Is able to step over box but must slow down and adjust steps to
clear box safely.
(2) Steps over box with moderate loss of balance.
(1) Moderate impairment: Is able to step over box, but must stop, then step over. May
require verbal cueing.
(0) Severe impairment: Cannot perform without assistance.
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7. Step around obstacles (cones) _____next task: diagonal long block
obstacle
Instructions:

“When I tell you to begin walking down the grid. When you come to the first
cone, walk on the outside of it and keep walking. When you reach the second
cone, walk around the outside of it and keep walking.”

[Therapist walks to side]

“Begin walking at your normal speed now by walking around the cones, not over
them.”

Grading: Mark the lowest category that applies.
(5) Normal: Is able to walk around cones safely without changing gait speed; no
evidence of imbalance.
(4) Walks around cones with slight loss of balance or slight step out of gait pattern.
(3) Mild impairment: Is able to step around both cones but must slow down and
adjust steps to clear cones.
(2) Walks around cones with moderate loss of balance.
(1) Moderate impairment: Is able to clear cones, but must significantly slow speed to
accomplish task or requires verbal cueing.
(0) Severe impairment: Unable to clear cones, walks into one or both cones, or
requires physical assistance.

79

8. Diagonal Obstacle (block) _____

next task: step on/off

platform
Instructions:

“When I tell you to begin, walk at your normal speed from here to the end of the grid
and stop. When you come to an obstacle, step over it, not around it, and keep
walking.”

[Therapist walks to side]

“Begin walking at your normal speed now by stepping over the obstacles, not
around.”

Grading: Mark the lowest category that applies.
(5) Normal: Is able to step over obstacle safely without changing gait speed; no
evidence of imbalance.
(4) Steps over obstacle with either slight imbalance or slight step out of gait pattern.
(3) Mild impairment: Is able to step over obstacle but must slow down and adjust
steps or makes contact with box
(2) Walks over obstacle with moderate loss of balance.
(1) Moderate impairment: Is able to step over box, but must stop, then step over. May
require verbal cueing.
(0) Severe impairment: Cannot perform without assistance.
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9. Step up/Step down (platform) _____
Instructions:
“When I tell you to begin, walk at your normal speed from here to the end of the
grid and stop. When you come to the platform, step up and continue walking
forward, step down and continue walking to the end of the grid.”

[Therapist walks to side]

“Begin walking at your normal speed now by walking onto and off of the
platform.”

Grading: Mark the lowest category that applies.
(5) Normal: Is able to step up/down off platform without changing gait speed; no
evidence of imbalance.
(4) Steps up/down off platform with slight imbalance or slight step out of gait pattern.
(3) Mild impairment: Is able to step up/down off platform but must slow down and
adjusts steps for on/off platform.
(2) Steps up/down off platform with moderate loss of balance.
(1) Moderate impairment: Is able to step up/down off platform, but must stop. May
require verbal cueing.
(0) Severe impairment: Cannot perform without assistance.

.
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Appendix G: Consent Form

UNIVERSITY OF WISCONSIN – MILWAUKEE
CONSENT TO PARTICIPATE IN RESEARCH
THIS CONSENT FORM HAS BEEN APPROVED BY THE IRB FOR A ONE YEAR PERIOD

1. General Information
Study title:
Role of Bifocal Lens Glasses on Walking Balance

Person in Charge of Study (Principal Investigator):
My name is Dr. Kurt Beschorner. I am an assistant professor in the Department of
Industrial Engineering at University of Wisconsin-Milwaukee.
2. Study Description
You are being asked to participate in a research study. Your participation is completely
voluntary. You do not have to participate if you do not want to.
Study description:
The purpose of this study is to learn more about the role of bifocal lens glasses on
walking balance.
The long-term goal of this project is to develop interventions that reduce falling accidents
in people who wear bifocal lens glasses. This study is meant to identify changes in
walking balance that occur in subjects wearing bifocal glasses compared with those
wearing single lens glasses.
The study is being conducted in the Gait and Biodynamics Laboratory at UWM. Twenty
subjects will participate in the study. All subjects will be tested at the same site. Your
participation will take approximately 1.5 hours over the course of 1 day.
3. Study Procedures
What will I be asked to do if I participate in the study?
Are you currently pregnant, think you could be pregnant, or trying to become pregnant?
If the answer is “YES” you will are disqualified from study enrollment for this protocol.
If the answer is “NO” you could be included, assuming you meet all other study inclusion criteria.
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At the testing session, you will wear tight fitting clothing, be instrumented with different
sensors and be asked to walk several times. Seventy-six (76) spherical sensors will be
attached to your skin using double-sided tape. Sensors will be attached to your feet, legs,
hips, arms, shoulders, head, neck and one will be placed on your chest just above the
collarbone. Care will be taken during placement and removal of sensors and you should
not expect any lasting discomfort related to placement or removal of sensors. Placement
and removal of markers will feel similar to "placing and removing a band-aid". You will
also have small sensors attached to different muscles on your legs and arms. These
sensors measure muscle activity and are similar to ECG’s, which measure heart activity.
You will be asked to walk several times (no more than 40 laps or half a mile) on a loop
course. During this period, you will be performing two tasks. During the first task, you
will be walking on flat terrain, ramps and steps. During the second task, you will be
performing a functional balance test, which consists of 9 separate tasks walking tasks.
These may include requiring you to turn your head while walking or step over objects.
You will wear both standard non-prescription single lens glasses and non-prescription
bifocal lens glasses during the testing. You will wear a safety harness, which will be
attached to an overhead harness system during testing to protect you from hitting the
ground in case of a fall.
Throughout the testing, your motion will be captured through a system that tracks the
spherical sensors on your body. In addition, your muscle activity will also be recorded.
We will also video record you, while you walk. The video-recordings are performed so
that we can watch your movements, which is helpful in analyzing the data. You may
choose to not be recorded without an effect on your eligibility. We will also use the video
recordings to describe our experiments to colleagues and at scientific conferences. This
data is necessary to determine what changes in walking balance due to the corrective lens
glasses. This task will last approximately 1 hour.
4. Risks

and Minimizing Risks

What risks will I face by participating in this study?
Physical: There are some physical risks from this study. There is a rare risk (<1%) that
you might fall and experience an injury. You will wear a harness so that if you fall as you
walk on the ramp or step surfaces, you will not hit the ground.
Social: There are no foreseeable social risks for participating in this research study.
Psychological: There are no foreseeable psychological risks for participating in this
research study.

5. Benefits
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Will I receive any benefit from my participation in this study?
You will receive $30.00 check for the 1.5 session. You might also benefit from your
participation in this study by learning about how bifocal lens glasses affect your balance.
6. Study Costs and Compensation
Will I be charged anything for participating in this study?
You will not be responsible for any of the costs from taking part in this research study.
Are subjects paid or given anything for being in the study?
You will receive $30.00 check for the 1.5 hour session.
7. Confidentiality

What happens to the information collected?
All information collected about you during the course of this study will be kept
confidential to the extent permitted by law. We may decide to present what we find to
others, or publish our results in scientific journals or at scientific conferences.
Information that identifies you personally will not be released without your written
permission. Only the PI and Co-I will have access to the information. However, the
Institutional Review Board at UW-Milwaukee or appropriate federal agencies like the
Office for Human Research Protections may review this study’s records.
You will be identified on your data files with a made-up initial and a number. Your name
will not appear anywhere and no one will know about your answers, or see your data
except the research team.
All data will be saved in the password protected files and computers in a secure room
with access limited only to research team members. The laboratory is in building with
keycard access afterhours on weekdays and on weekends. All of the information and data
collected for this study will be stored in the files and portable hard drive in a locked file
cabinet in the Gait Analysis and Biodynamics Laboratory at UWM for 5 years for future
use.
8. Alternatives

Are there alternatives to participating in the study?
There are no known alternatives available to you other than not taking part in this study.
9. Voluntary

Participation and Withdrawal

What happens if I decide not to be in this study?

84
Your participation in this study is entirely voluntary. You may choose not to take part in
this study. If you decide to take part, you can change your mind later and withdraw from
the study. You are free to not answer any questions or withdraw at any time. Your
decision will not change any present or future relationships with the University of
Wisconsin Milwaukee.
If you decide to withdraw or if you are withdrawn from the study before it ends, we will
use the information we collected up to that point.
10. Questions

Who do I contact for questions about this study?
For more information about the study or the study procedures or treatments, or to
withdraw from the study, contact:
Dr. Kurt Beschorner (PhD)
College of Engineering and Applied Science
Industrial and Manufacturing Engineering
University of Wisconsin-Milwaukee
USR Building, Room 201C
4090 N 1st St., Milwaukee, WI 53212
Phone: (414)229-6403
Who do I contact for questions about my rights or complaints towards my
treatment as a research subject?
The Institutional Review Board may ask your name, but all complaints are kept in
confidence.
Institutional Review Board
Human Research Protection Program
Department of University Safety and Assurances
University of Wisconsin – Milwaukee
P.O. Box 413
Milwaukee, WI 53201
(414) 229-3173
11. Signatures
Research Subject’s Consent to Participate in Research:
To voluntarily agree to take part in this study, you must sign on the line below. If you
choose to take part in this study, you may withdraw at any time. You are not giving up
any of your legal rights by signing this form. Your signature below indicates that you
have read or had read to you this entire consent form, including the risks and benefits,
and have had all of your questions answered, and that you are 18 years of age or older.
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_____________________________________________
Printed Name of Subject/ Legally Authorized Representative
_____________________________________________
Signature of Subject/Legally Authorized Representative

_____________________
Date

Research Subject’s Consent to Audio/Video/Photo Recording:
It is okay to videotape me while I am in this study and use my videotaped data in the
research.
Please initial: ____Yes

____No

Principal Investigator (or Designee)
I have given this research subject information on the study that is accurate and sufficient
for the subject to fully understand the nature, risks and benefits of the study.
_____________________________________________
Printed Name of Person Obtaining Consent

_____________________
Study Role

_____________________________________________
Signature of Person Obtaining Consent

_____________________
Date
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Appendix H: IRB

Protocol Summary
Instructions: In order to review research involving human subjects, the UWM IRB requires the completion
and submission of the New Study Application Form and a Protocol Summary. The following guidelines are
designed to help researchers develop a comprehensive yet concise research protocol to facilitate timely
review by the IRB. Please note, Capstone, thesis, dissertation, grant, and funding proposals cannot be
submitted as, or in lieu of, this Protocol Summary as they do not contain all the required information
(45CFR46).
Each Section must be completed unless directed otherwise. Incomplete forms will delay the IRB review
process and may be returned to you. Enter your information in the colored boxes. The boxes will expand as
you type.
SECTION A: Title and Date
Note that the study title must be the same on all study documents (e.g., consents, advertisements, grants,
etc.). If not, a reason must be given in the Protocol Summary Form Section I.
Role of Bifocal Lens Glasses on Walking Balance
A1. Project Title:

A2. Today’s Date:

9/23/2010

SECTION B: Project Purpose/ Research Question/ Objectives
In non-technical language, address the following:
1) Area of the research
2) Describe the purpose/objective
3) Significance of the research is
4) Any relevant literature pertaining to the proposed research study

1) Balance, vision
2) The long term goal of this project is to develop interventions that reduce the number
of falling accidents in older adults wearing bifocal/multifocal lens glasses. The proposed
research is needed to develop and validate a walking task that is sensitive to balance and
gait changes that occur when subjects wear bifocal/multifocal lens glasses as opposed to
single-lens glasses.
3) Falling accidents are a major cause of injuries, especially for older adults. Falling
accidents often occur when a person is not able to adapt to changes in their environment.
Adapting to changes in the environment requires proactive and reactive responses.
Proactive responses include gait adjustments such as modifying step length, cadence,
muscle activation patterns and foot trajectories in anticipation of an obstacle. Reactive
patterns include generating a postural response to a perturbation through muscle
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activations in the legs and arms in response to an unexpected perturbation. This study
will examine the ability of young adults to proactively adapt to changes in their walking
environment while either wearing bifocal lens glasses or single lens glasses. Developing
and validating the measures and walking course is necessary to measuring the
effectiveness of interventions on improving proactive feedback to environmental
changes for bifocal/multifocal lens wearers.
4) Previous research has indicated that bifocal/multifocal lens glasses wearers have an
increased risk of falling (Lord et al., 2002). Bifocal/multifocal lens glasses blur and/or
distort vision in the bottom part of the field of view, which reduces a person’s ability to
identify ground-level obstacles and negotiate unexpected changes in ground level
terrain. Johnson et al. has shown that persons wearing multifocal lens glasses have
greater variability in toe clearance when ascending variable height steps compared with
single lens glass wearers (Johnson et al., 2007). Incorrect perception of the height and
angle of steps and ramps lead to increases in toe clearance variability (Johnson et al.),
slower gait speed (Menant et al.) and increases in muscle activity (van der Linden et al.,
2007). While the effect of bifocal/multifocal lens glasses on fall risk is well
documented, few interventions have been shown to be successful. Testing interventions
in a laboratory setting requires that a course be built and validated for its capability to
test subjects’ ability to perform functional activities while negotiating subtle changes in
the flooring. This study aims at identifying these biomechanical changes by having
subjects negotiate a course that includes a ramp and step, while wearing single lens
glasses and multifocal lens glasses.
Lord, S., J. Dayhew, B. Sc, and A. Howland, Multifocal Glasses Impair Edge-Contrast
Sensitivity and Depth Perception and Increase the Risk of Falls in Older People.
Journal of the American Geriatrics Society, 2002. 50(11): p. 1760-1766.
Johnson, L., J. Buckley, A. Scally, and D. Elliott, Multifocal spectacles increase
variability in toe clearance and risk of tripping in the elderly. Investigative
ophthalmology & visual science, 2007. 48(4): p. 1466.
Menant, J.C., R.J.S. George, B. Sandery, R.C. Fitzpatrick, and S.R. Lord, Older People
Contact More Obstacles When Wearing Multifocal Glasses and Performing a
Secondary Visual Task. Journal of the American Geriatrics Society, 2009.
57(10): p. 1833-1838.
M. H. van der Linden, D. S. Marigold, F. Gabreëls, and J. Duysens, Muscle Reflexes and
Synergies Triggered by an Unexpected Support Surface Height During Walking.
J Neurophysiol, 2007. 97: p. 3639-50.

SECTION C: Recruitment and Consent/Assent
Describe the following:
1) How the recruitment will take place. E.g., through flyers, beginning announcement for X class,
referrals, random telephone sampling, etc.
2) Inclusion criteria. E.g., age, gender, health status/condition, ethnicity, location, English
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speaking, etc.
3) Exclusion criteria. E.g., age, gender, health status/condition, ethnicity, location, English
speaking, etc.
4) How consent/assent will take place. E.g., in person, online web survey, “request to waive
consent” as this is secondary data analysis only, etc.
a. If participants do not speak English as a first language or might have trouble
comprehending the consent, describe the process for obtaining consent (e.g., translated
consent, verbal consent, etc.).

1) Step A: Recruitment will take place through flyers place around campus and the
surrounding community and through word-of-mouth. These flyers will include the
phone number of our lab and the name of the study.
Step B: Subjects who call will be given additional information about the study will
complete a questionnaire over the phone to determine eligibility. The subject will be
asked to provide verbal consent to participate in the questionnaire. The phone
conversation will be performed using a script although the researcher will be allowed to
go off script to answer questions that the subject might have. If the subject appears to
meet all of the eligibility requirements and is still interested in participation of the study,
the researcher will then schedule a visit.
Step C: Subjects will review and complete the consent form prior to testing. Subjects
will be provided as much time to review the consent as they need. The consent form will
be verbally explained to the subjects to ensure that they are aware of the purpose,
protocol and risks of the study. Once the subject is familiar with the consent, they will
sign it in the presence of the researcher.
2) Healthy adults between the ages of 18 and 35 or 45 and 60 will be included in this
study.
3) Children under the age of 18 years old will not be included in this study. Children do
not typically wear bifocal/multifocal lens glasses and are therefore not at a high risk for
fall injuries due to bifocal/multifocal lenses in the public sector. Therefore, we believe
that this research would have a limited benefit to this group.
Pregnant women or women that think they could be pregnant will not be recruited for
this study in order to protect an unborn child and a mother from the risks associated with
falling into the harness during testing.
Subjects with osteoarthritis will be excluded from the study because joint pain might
impede their ability to respond to the slipping perturbation.
Subjects with osteoporosis will be excluded from the study because they will be at
increased risk of injury due to the fall.
Subjects with musculoskeletal disorders, sensory disorders or take medication that affect
their ability to walk normally will be excluded as these are special populations that are
not representative of the general population. (Modification for Item 1)
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Subjects who weigh over 300 pounds will not be included due to concerns with the
harness system.
Non-bifocal wearing subjects who have vision impairments that are not corrected with
contact lenses will be excluded from the study. The study requires that subjects wear
non-prescription bifocal lens glasses, which cannot be placed over another set of glasses
and so subjects must be able to see properly without glasses. Experienced bifocal
wearing subjects that do not have both single lens and bifocal lens glasses will also be
excluded.
Subjects who do not speak English will not be recruited.
4) The consent form will be administered by a PI or member of the research team who
will be available to answer all of the individual’s questions prior to their participation.
PI and/or research team member will meet with those individuals who do not meet the
exclusion criteria, explain the consent and study procedures. This consent form will
outline the study, the risks and benefits to the individual participating, and inform the
individual that they are free to withdraw from the study at any time. Once subject
understands the scope and has no further questions, he/she will sign an informed
consent, complete the questionnaire and be scheduled for their biomechanical testing
session at Gait and Biodynamics Laboratory at UWM. All individuals participating in
the study will be required to sign an informed consent approved by the University of
Wisconsin Milwaukee’s Institutional Review Board (IRB).

SECTION D: Data Collection and Design
In non-technical language, address the following:
1) Chronologically state the study activities. Describe both the activities conducted by the PI and
the research participants. (E.g., screening, survey, taking a test, answering questions in an
interview, completing a specific task, tasks on a computer, running on a treadmill, debriefing,
etc.). If videotaping, photographs, or audiotaping will take place, explain for what and why.
2) Explain how the data will be analyzed or studied (i.e. quantitatively or qualitatively) and how
the data will be reported (i.e. aggregated, anonymously, pseudonyms for participants, etc.).

1)
A. Specific Aims
A.1. Specific Aim #1: Identify gait characteristics that occur between single lens
glasses wearers and multifocal lens glasses wearers. This specific aim will identify
gait changes that occur while approaching a step/ramp ascending the step/ramp and
descending a ramp/step between single lens glasses and bifocal lens glass wearers.
Hypothesis 1 (H1): There will be a significant difference in gait speed as the
subject approaches the step between subjects wearing single lens and bifocal glasses.
Hypothesis 2 (H2): Toe clearance variability will increase for subjects wearing
bifocal lens glasses compared with subjects wearing single lens glasses.
Hypothesis 3 (H3): Muscle activity will increase while negotiating the ramp and
steps in subjects wearing multifocal lens glasses compared with subjects wearing single
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lens glasses.
B. Approach
The proposed research will examine the effects of bifocal lens glasses on subjects’
ability to negotiate ramps with variable pitch and steps of variable heights.
B.1. Apparatus for Specific Aims #1 and #2
Several different measures will be collected during data collection. Whole body motion
will be collected based on a modified version of the Cleveland Clinic marker set. A 13
rigid body segment model will be applied to the marker data for the following segments:
feet, shanks, thighs, pelvis, torso, upper arms, lower arms and head similar to Moyer et
al (2006). Two force plates will record subjects’ ground reaction forces prior to
ascending the stair/ramp and while stepping off of the ramp/stair. An overhead harness
system will support the subjects in the case of a fall or stumble. Lastly, an EMG system
will record muscle activity of the rectus femoris, medial hamstring, tibialis anterior and
medial gastrocnemius. These muscles will specifically be examined, as they are known
to be part of the postural response during perturbations.
B.2. Specific Aim #1
B.2.1. Protocol: Twenty subjects will be recruited to participate in this part of the study.
Prior to data collection, subjects will be fitted with a set of reflective markers and
electromyography sensors. Subjects will don a harness that will be connected to a trolley
system that is attached to an I-beam to keep the subjects from hitting the ground in the
event of an irrecoverable fall. In addition, subjects will be given tight-fitting clothing to
minimize marker error due to skin artifact. Subjects will wear their own shoes. Subjects
will have 76 markers placed on different anatomical landmarks of their feet, shanks,
thighs, pelvis, torso, upper arms, lower arms and head (Modification from Item 5).
Subjects will walk through a loop course (~200 feet long), which will consist of two
tasks: 1) negotiating step/ramp task and 2) get-up-and-go task. Subjects will perform 18
laps around this course while wearing single lens glasses and 18 laps while wearing
bifocal lens glasses. The bifocal lens glasses will not be prescription and will be worn
both by subjects not requiring corrective lenses and by subjects wearing contact lens
glasses. Subjects requiring corrective lenses will wear contact lenses in addition to the
glasses during testing (Modification from Item 2). The order of glasses conditions will
be randomized.
Step/Ramp Task: Subjects will perform 3 trials of each of 6 different ramp/step
conditions for each glasses condition. For each trial, subjects will either walk up a ramp
and then down a step (ramp-step) or walk up a step and then down a ramp (step-ramp).
Three different conditions will be used for the height and pitch of the ramps and steps:
1) the ramp will be pitched at 1” rise per foot of run (this is a standard ramp pitch) and a
3” step; 2) the ramp will be pitched at 2” rise per foot of run and a 6” step; and 3) the
ramp will be pitched at 2” rise per foot with two 3” steps.
The Dynamic Gait Index (DGI) is a well validated instrument that is often used to
measure functional mobility in the older population and for specific populations of
people with disabilities (Shumway-Cook & Woollacott, 2001; Chiu, et al., 2004).The
DGI consists of a 20 foot walkway with the participant engaging in 9 tasks, such as
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turning the head while walking, stepping over an obstacle, etc. The participant is rated
on a 0-5 scale by a trained observer. Participants will complete each task 4 times, twice
with single lens glasses, and twice with bifocal glasses to match the number of trials
with the step/ramp. The primary purpose of including the DGI in this study is to Beta
test the logistics of setting up the track, changing the obstacles, etc., in order to access
the time and number of researchers needed to ensure optimal operation.
B.2.2. Data Analysis: To determine differences between the bifocal condition versus
the single lens condition, toe clearance variability, gait speed and electromyography will
be analyzed. Toe height variability will be analyzed for each subject during step-up,
step-down, walking up the ramp and walking down the ramp conditions as the minimum
height of a marker placed on the toe during 20 and 80% of swing. In addition, gait speed
and gait speed variability will be measured by the whole body center of mass velocity
during the 2 steps preceding the ramp up or step up condition. Lastly, EMG’s will be
filtered using a high-pass filter to eliminate motion artifact at 20Hz, full-wave rectified
and then low-pass filtered, similar to Marigold et al. (2002). The peak muscle activity
will be the primary variable analyzed. Additional data will be collected for further
exploratory analyses including joint angles and ground reaction forces while
approaching the ramp/step and while stepping off of the ramp/step.
Subjects will be scored by a trained rater on their proficiency for each DGI task on a
scale of 0 (severe performance problems) to 5 (no performance problems). The scores
for the 9 tasks are then combined to form a 0-45 point score.
Subjects’ motion will be recorded using motion capture technology that records the
motion of reflective markers placed on anatomical landmarks. In addition, subjects will
be videotaped so that irregularities in testing can be identified post-hoc.
Moyer, B., Slip and Fall Risks: Pre-Slip Gait Contributions and Post-Slip Response
Effects, in Bioengineering. 2006, University of Pittsburgh: Pittsburgh.
Marigold, D.S. and A.E. Patla, Strategies for dynamic stability during locomotion on a
slippery surface: effects of prior experience and knowledge. J Neurophysiol,
2002. 88(1): p. 339-53.
Shumway-Cook & woollacott, M.H. (2001). Motor control: Theory and practical
applications (3rd ed.) Philadelphia: Lippincott Williams & Wilkins.
Chui, Y., Fritz, S.L., Light, K.E., & Velozo, C.A. (2006). Use of item response analysis
to investigate measurement properties and clinical validity of data for the
Dynamic Gait Index. Physical Therapy, 86(6), p. 778-787.
2) Statistical Analyses:
Data will be compared for each of the 6 ramp conditions across subjects using paired ttests between the bifocal conditions and the single lens glass conditions. Seven variables
will be analyzed for 6 different conditions. Because of the exploratory nature of this
pilot study, no statistical adjustments will be made.
Data from the DGI trial analysed using paired t-tests between glasses conditions. The
DGI data will also be correlated with the data from the 6 ramp conditions.
A subject number will be assigned to each subject and all subjects will be analyzed
using this de-identified subject number.
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SECTION E: Risks to Subjects
Research risk is the probability of harm occurring as a result of participation in research. In nontechnical language, address the following:
1) The types of risks (e.g., physical, psychological, social, economic, legal, etc.) the subject may
reasonably encounter.
2) Identify the frequency/likelihood of those risks.
3) Describe the procedures/process which will reduce or minimize risks:
a. How the data will be safeguarded (e.g., data is anonymous, assigning pseudonyms,
coded, etc.).
b. Where data will be stored and who will have access to it.
c. What will happen to the data after the study is complete.
b. What happens if the participant gets hurt or upset? E.g., referred to Norris Health
Center, PI will stop the interview, given telephone hotlines for abuse, etc.

1) Subjects will be exposed to minor risks from being exposed to the ramp/stair during
the protocol. A harness system will be used to prevent subjects from hitting the ground
in the case of an irrecoverable fall so this risk will be minimal.
There are no known psychological or social risks from this testing protocol.
The PI has worked extensively on projects using harness technologies to prevent falling
accidents after subjects experience destabilizing perturbations. During the PI’s
dissertation work at the University of Pittsburgh, he extensively studied the
biomechanics of slip and fall accidents. Across 3 different studies, over 100 subjects
experienced a slip and approximately half of those subjects fell into the harness after the
slip. These studies included both young and older adults. No injuries were ever
experienced in any of those slips because the harness prevented the subjects from falling
to the ground. We expect the risk will be less in the proposed study because: 1) all
subjects will be young and healthy and 2) the subjects will not be perturbed with a slip
or trip.
2) We expect the risks as being rare. The risk of injury from the induced fall is expected
to be <1%.
3) All data will be kept confidential to the extent permitted by law. Research team
members may decide to present what we find to others, or publish our results in
scientific journals or at scientific conferences. Only the PI and research team personnel
will have access to the information. On all data sheets and computer files, the subject
will be identified by a number randomly assigned to the subject when admitted into the
study. The only document linking the subject’s name to the number will be the informed
consent, which will be locked in a file cabinet with the PI and Co-I as the only person’s
with access.
All data will be saved in password protected files and computers in a secure room with
access limited only to research team members. All of the information and data collected
for this study will be stored in the files and portable hard drive in a locked file cabinet in
Gait Analysis and Biodynamics Laboratory at UWM for 5 years for future use.
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SECTION F: Benefits
1) Describe any direct benefits participants could potentially receive. If there are no direct
benefits, explain.
2) Explain how the risks compare to benefits.
3) If monetary or gift compensation will be given to subjects, explain:
d. In what form (i.e., cash, check, pens, etc.,).
e. The amount or approximate value.
f. When the participant will receive the item (e.g., $5 after completing each survey,
subject will receive [item] even if they do not complete the procedure).
4) If extra credit will be offered, explain:
a. If an alternative task that is not study related will be offered for the same extra credit.
b. If the task is a class requirement/assignment that students would be required to complete
even if the study was not being conducted.
1) The subjects may experience some benefit by learning how bifocal lens glasses affect their ability to
negotiate changes in flooring. In addition, subjects may gain an understanding of biomechanics research
topics. Subjects will receive compensation of $30.
2) We anticipate risks to the subject will be slight and will occur rarely. We expect that the subjects will
be exposed to a minimal amount of risk and will receive a limited amount of benefit from the study. The
research will be used to identify changes in walking patterns on ramps and steps while wearing bifocal
lens glasses compared with single lens glasses, which is critical to developing intervention to improve
balance of person’s wearing bifocal glasses. Therefore, we anticipate that this study will result in a great
amount of societal benefit.
3) Subjects will be paid $30 for their participation.
4) N/A

SECTION G: Deception/ Incomplete Disclosure (INSERT “NA” IF NOT APPLICABLE)
If you cannot adequately state the true purpose of the study to the subject in the informed consent,
deception/ incomplete disclosure is involved.
1) Describe the deception/ incomplete disclosure of information to the subjects.
2) Explain why such deception/ incomplete disclosure is necessary.
3) Explain the debriefing process, or explain why there will not be a debriefing process.
1) N/A
2) N/A
3) N/A

SECTION H: Conflicts of Interest
When researchers are involved with commercial ventures, there is the potential for diverting from their
primary mission of research and education. Conflicts of interest can arise when the interests of the
commercial venture differ from the interests and primary obligations of the researcher, or when the
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commercial venture consumes an undue share of employee time. Contact the Graduate School Research
Services and Administration for more information.

Reminders:
1. Make sure all questions that are applicable have been answered on this form.
2. Responses should be consistent with other forms (e.g., New Study Submission Form, Consent
Form, etc.).

New Study Form
Instructions: Each Section must be completed unless directed otherwise. Incomplete forms will delay the
IRB review process and may be returned to you. Enter your information in the colored boxes or place an
“X” in front of the appropriate response(s).
SECTION A: Title & Date
Section Notes…
• Study title must be the same on all study documents (e.g., consents, advertisements, grants, etc.).
If not, a reason must be given in the Protocol Summary Form.
• Mismatched titles between what the IRB approves and what is on the grant application may
delay funding.
A1. Study
Title:

Role of Bifocal Lens Glasses on Walking Balance

A2. Today’s Date:
9/23/2010

SECTION B: Investigators & Study Personnel
Section Notes…
• IRB correspondence (e.g., Approval Letters, IRB revisions, etc.) will be emailed to the email
addresses listed under the PI and contact person (B1 and B2).
• Only UWM faculty and staff may be listed as PI. However, students may be listed as a Student
PI in B2.
B1. Principal Investigator (P.I.) (UWM faculty and staff only):
Name:

Kurt Beschorner, Ph.D.

Degree(s):

PhD

Title/Position:

Assistant Professor

Department:

Industrial Engineering

Telephone:

(414)229-6403

Email:

beschorn@uwm.edu

B2. Student Principal Investigator (S.P.I.) or Other Contact than PI:
Name:

Degree(s):
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Telephone:

Email:

B3. Co-Investigators and Research Personnel and identify their role in the study (e.g., Co-PI,
Research Assistant, Graduate Student, etc) (if applicable). Add additional rows or attach addendum if more
personnel requires listing than space provided:
Name:

Roger Smith, Ph.D.

Study Role:

Co-PI

Name:

Dennis Tomashek

Study Role:

Researcher Specialist

Name:

Autumn Milanowski

Study Role:

Data Collection

Name:

Study Role:

SECTION C: Review Type Requested
Section Notes…
• C1: “Minimal Risk” is when the probability and magnitude of harm or discomfort anticipated in the
proposed research are not greater, in and of themselves, than the harm and discomfort ordinarily
encountered in daily life or during the performance of routine physical or psychological examinations
or tests. For example, the risk of drawing a small amount of blood from a healthy individual for
research purposes is no greater than the risk of doing so as part of routine physical examination.
• C3: The most common Exempt Category for a social science study is 2. To help determine if your
study qualifies for Exempt Status, see the checklist the IRB Reviewer uses.
• C4: The most common Expedited Category for a social science study is 7.
• Upon review, the IRB office may change the requested type of review. Disqualifiers from exempt or
expedited may include but not limited to: use of deception; studies involving minors, prisoners,
pregnant women, impaired adults, or students; study of illegal activities like drug use; or study of
private activities like sexual behavior.
C1. Are the human subjects at more than “minimal risk”? More than minimal risk will require Full
Board Review. Place an “X” next to the appropriate response.
[__] Yes
[_x_] No
C2. Will the study involve deception or incomplete disclosure to human subjects? Place an “X” next to
the appropriate response.
[__] Yes
[_x_] No
C3. I am requesting the following review by the IRB: (Select “a”, “b”, or “c”. If “b” or “c” is
selected, continue by selecting the appropriate category.) Place an “X” next to the appropriate response.
[__] a. Full Board Review (e.g., greater than minimal risk, the combination of a vulnerable population
and sensitive information being collected, invasive procedures excluding blood draws); OR
[__] b. Exempt Review where there is no more than “minimal risk” under (select all that apply)…
OR
[__] Category 1 Research conducted in established or commonly accepted educational settings,
involving normal educational practices, such as (i) research on regular and special
education instructional strategies, or (ii) research on the effectiveness of or the comparison
among instructional techniques, curricula, or classroom management methods.
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[__] Category 2 Research involving the use of educational tests (cognitive, diagnostic, aptitude,
achievement), survey procedures, interview procedures or observation of public behavior,
unless: (i) information obtained is recorded in such a manner that human subjects can be
identified, directly or through identifiers linked to the subjects; and (ii) any disclosure of the
human subjects' responses outside the research could reasonably place the subjects at risk of
criminal or civil liability or be damaging to the subjects' financial standing, employability,
or reputation.
[__] Category 3 Research involving the use of educational tests (cognitive, diagnostic, aptitude,
achievement), survey procedures, interview procedures, or observation of public behavior
that is not exempt if: (i) the human subjects are elected or appointed public officials or
candidates for public office; or (ii) federal statute(s) require(s) without exception that the
confidentiality of the personally identifiable information will be maintained throughout the
research and thereafter.
[__] Category 4 Research involving the collection or study of existing data, documents,
records, pathological specimens, or diagnostic specimens, if these sources are publicly
available or if the information is recorded by the investigator in such a manner that subjects
cannot be identified, directly or through identifiers linked to the subjects.
[__] Category 5 Research and demonstration projects which are conducted by or subject to the
approval of department or agency heads, and which are designed to study, evaluate, or
otherwise examine: (i) Public benefit or service programs; (ii) procedures for obtaining
benefits or services under those programs; (iii) possible changes in or alternatives to those
programs or procedures; or (iv) possible changes in methods or levels of payment for
benefits or services under those programs.
[__] Category 6 Taste and food quality evaluation and consumer acceptance studies.
[_x_] c. Expedited Review under where there is no more than minimal risk and (select all that
apply)…
[__] Category 1 Clinical studies of drugs and medical devices only when condition (a) or (b) is
met. (a) Research on drugs for which an investigational new drug application (21 CFR Part
312) is not required. (Note: Research on marketed drugs that significantly increases the
risks or decreases the acceptability of the risks associated with the use of the product is not
eligible for expedited review.) (b) Research on medical devices for which (i) an
investigational device exemption application (21 CFR Part 812) is not required; or (ii) the
medical device is cleared/approved for marketing and the medical device is being used in
accordance with its cleared/approved labeling.
[__] Category 2 Collection of blood samples by finger stick, heel stick, ear stick, or
venipuncture as follows: (a) from healthy, nonpregnant adults who weigh at least 110
pounds. For these subjects, the amounts drawn may not exceed 550 ml in an 8 week period
and collection may not occur more frequently than 2 times per week; or (b) from other
adults and children, considering the age, weight, and health of the subjects, the collection
procedure, the amount of blood to be collected, and the frequency with which it will be
collected. For these subjects, the amount drawn may not exceed the lesser of 50 ml or 3 ml
per kg in an 8 week period and collection may not occur more frequently than 2 times per
week.
[__] Category 3 Prospective collection of biological specimens for research purposes by
noninvasive means.
Examples: (a) hair and nail clippings in a nondisfiguring manner; (b) deciduous teeth at
time of exfoliation or if routine patient care indicates a need for extraction; (c) permanent
teeth if routine patient care indicates a need for extraction; (d) excreta and external
secretions (including sweat); (e) uncannulated saliva collected either in an unstimulated
fashion or stimulated by chewing gumbase or wax or by applying a dilute citric solution to
the tongue; (f) placenta removed at delivery; (g) amniotic fluid obtained at the time of
rupture of the membrane prior to or during labor; (h) supra- and subgingival dental plaque
and calculus, provided the collection procedure is not more invasive than routine
prophylactic scaling of the teeth and the process is accomplished in accordance with
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accepted prophylactic techniques; (i) mucosal and skin cells collected by buccal scraping or
swab, skin swab, or mouth washings; (j) sputum collected after saline mist nebulization.
[_x_] Category 4 Collection of data through noninvasive procedures (not involving general
anesthesia or sedation) routinely employed in clinical practice, excluding procedures
involving x-rays or microwaves. Where medical devices are employed, they must be
cleared/approved for marketing. (Studies intended to evaluate the safety and effectiveness
of the medical device are not generally eligible for expedited review, including studies of
cleared medical devices for new indications.)
Examples: (a) physical sensors that are applied either to the surface of the body or at a
distance and do not involve input of significant amounts of energy into the subject or an
invasion of the subject’s privacy; (b) weighing or testing sensory acuity; (c) magnetic
resonance imaging; (d) electrocardiography, electroencephalography, thermography,
detection of naturally occurring radioactivity, electroretinography, ultrasound, diagnostic
infrared imaging, doppler blood flow, and echocardiography; (e) moderate exercise,
muscular strength testing, body composition assessment, and flexibility testing where
appropriate given the age, weight, and health of the individual.
[__] Category 5 Research involving materials (data, documents, records, or specimens) that
have been collected, or will be collected solely for nonresearch purposes (such as medical
treatment or diagnosis).
[__] Category 6 Collection of data from voice, video, digital, or image recordings made for
research purposes.
[__] Category 7 Research on individual or group characteristics or behavior (including, but not
limited to, research on perception, cognition, motivation, identity, language,
communication, cultural beliefs or practices, and social behavior) or research employing
survey, interview, oral history, focus group, program evaluation, human factors evaluation,
or quality assurance methodologies.
SECTION D: Study Funding
Section Notes…
• D1: Federally funded studies (e.g., NIH, CDC, etc.) requires IRBs to review the grant application
for consistency in human protections. Submit 2 copies of the grant application.
D1. This study’s funding source is or will be:
[__] a. Federally Funded (e.g., NIH, CDC, FDA, NIOSH, DOE, DOJ, etc.)
[__] b. Industry, Foundation, Commercial, or Private
[__] c. Internal – Research Growth Initiative
[__] d. Internal – not Research Growth Initiative (e.g., department)
[_x_] e. Not Funded (SKIP TO SECTION E)
D2. If “a,” “b,” “c,” or “d” was selected in D1, complete this section:
a. Name of funding source(s):
b. Address of funding source(s):
c. UWM Proposal/ grant # (if applicable):
D3. If “a” or “b” was selected in D1, and the sponsor requires notification directly from the IRB,
complete this section. Provide the name and the method of transmission (address/ fax/ email) of the
individual who requested the notification. A letter will be prepared and forwarded.
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SECTION E: Study Locations
Section Notes…
Federal regulations require all institutions engaged in human subjects research that is not exempt from the
regulations and has adopted the Common Rule be covered by an OHRP approved assurance of compliance. The
Federalwide Assurance (FWA) is the only type of assurance accepted and approved by OHRP.
In general, an institution is considered to be engaged in human subjects research when its employees or agents:
(1) obtain data about living individuals for research purposes through intervention or interaction with them, or
(2) obtain individually identifiable private information for research purposes (45 CFR 46.102(d),(f))
http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm#46.102
Simply informing potential subjects about a research study is not considered engagement in research. Also,
providing written information about a research study, including how to contact the investigators for information
and enrollment, and seeking and obtaining prospective subjects’ permission for investigators to contact them
are not considered engagement in research. However, seeking or obtaining informed consent from a
research participant is considered engagement in research.
1.

2.

The Principal Investigator must contact the collaborating performance site to determine whether the
site has an active FWA. If they do not he/she should provide them with a copy of the IRB-appropriate
template (see below) and the link to the OHRP website
(http://www.hhs.gov/ohrp/assurances/assurances_index.html).
If a site does not have a registered IRB and the site requests to use UWM’s IRB as the IRB of Record,
the Principal Investigator is responsible for obtaining appropriate local authorization. Contact the IRB
office.

E1. Describe the location(s) where the study will take place. The location should not be limited to
interventions but also take into account recruitment, enrollment, data storage, and data analysis. For
example: recruitment at nursing homes, chart reviews at Froedtert Hospital, data storage at UWM
Engelmann Hall 270, etc.
All data collection will take place in the Center for Ergonomics at USR building, 2nd floor.

E2. List any other IRB, review committee, or institutional permission needed for this study and
explain the status for each. Attach appropriate approval letters. For example, “This study has also been
submitted to MATC’s IRB and is awaiting approval. Milwaukee Public School’s Research Committee has
already approved. Dr. Smith, the professor of Pych 101 has given me her permission to survey her class
(see email correspondence Appendix G).”

SECTION F: Study Duration
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F1. What is the expected start date? No study related activities (e.g., screening, recruitment, or
enrollment) can begin until IRB approval has been granted. Format: January 25, 2007
October 7, 2010
F2. What is the expected end date? Expected end date should take into account data analysis, queries,
and paper write-up. Format: July 1, 2009
October 6, 2011

SECTION G: Subject Population
G1. Does the study involve direct human subject participation? Place an “X” next to the appropriate
response.
[_x_] Yes
[__] No (e.g., secondary data analysis)
G2. State the subject group and total number to be enrolled for each group. For example, teachers-50,
students-200, parents-25, parent’s children-25, student control-30, student experimental-30, medical charts500, dataset of 1500, etc. If this is a multi-center study, enter the total number of subjects to be enrolled for
UWM. Total enrollment from all sites should be explained in the Protocol Summary Form.
Subject Group

Number

Adults (18-35 and 45-60)

40

TOTAL:

40

G3. This study involves (place an “X” next to all that apply)…
[__] a. Not Applicable (e.g., de-identified datasets)
OR
[__] b. Students of PI or study staff
[__] c. Students to be recruited in their educational setting, i.e. in class or at school.
[__] d. UWM Staff or Faculty
[__] e. Minors
[__] f. Prisoners
[__] g. Diagnosable Psychological Disorder
[__] h. Institutionalized
[__] i. Poor/uninsured
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[__] j.
[__] k.
[__] l.
[__] m.
[__] n.
[__] o.
[__] p.
[__] q.
[__] r.

Pregnant women
Fetuses
Nursing home residents recruited in the nursing home
Cognitively impaired
Psychiatrically impaired
Limited or non-readers
Wards of the state (e.g., foster children)
Terminally ill
Others vulnerable to coercion (Specify in the box below):

[_x_] s. Normal healthy subjects not requiring special protections
[__] t. Other (Specify in the box below):

SECTION H: Study Involvement
Section Notes…
• Internet Research is subject to additional guidelines. See IRB website.
H1. This study involves (place an “X” next to all that apply)…
[_x_] a. Datasets
[__] b. Interviews/Focus Groups
[_x_] c. Questionnaires/Surveys
[__] d. Observations
[_x_] e. Videotaping
[__] f. Audiotaping
[__] g. Photography
[__] h. Internet research
[__] i. Records Review (e.g., medical, educational tests/scores, etc.)
[__] j. Collection of Blood/ Blood Products
[__] k. Genetic Material
[__] l. Diagnostic imaging (e.g., MRI, fMRI, X-Rays, etc.) Ionizing radioactive materials or
radiation producing devices located here on campus requires the review and approval from the
Radiation Safety Program.
[__] m. Exposure to psychological stress
[__] n. Surgery
[__] o. Electrical Shock
[__] p. Chemical or Biological Agent (clinical)
[__] q. FDA for “off label” use
[__] r. Investigational New Device (clinical)
[__] s. Investigational Drug Exemption (clinical)
[__] t. Other invasive procedure (Specify in the box below):

SECTION I: Informed Consent Documents/ Assents
I1. How will the consenting of subjects take place? (place an “X” next to all that apply)…
[_x_] a. Written informed consent with the subject’s or legal representative’s signature. Use IRB
Template and attach to IRB submission. Go to Section M
[__] b. Waiver to obtain informed consent. E.g., dataset or chart study. Complete Section J
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[__] c. Waiver to alter the required elements of the informed consent document. E.g., survey conducted
over the telephone, short form of the consent. Complete Section J and Section K.
[__] d. Waiver to document informed consent. E.g., informed consent process if done verbally.
Complete Section k.
[__] e. Assent for minors. Use IRB Template. Complete Section L.
SECTION J: Request to Waive Informed Consent/ Request to Alter Informed Consent
Section Notes…
• Complete this section if you are requesting a Waiver to Obtain Consent or requesting to Alter
Informed Consent.
• Skip this section if you are not requesting a Waiver to Obtain Consent or requesting to Alter
Informed Consent.
• Answer all A’s OR all B’s
J1. Answer A’s OR B’s
[__] A1. The research or demonstration project is to be conducted by, or subject to the approval of,
state or local government officials, and is designed to study, evaluate, or otherwise examine: (i) public
benefit or service programs; (ii) procedures for obtaining benefits or services under those programs;
(iii) possible changes in or alternatives to those programs or procedures; or (iv) possible changes in
methods or levels of payment for benefits or services under those programs; and
Explain:

[__] A2. The research could not practicably be carried out without the waiver or alteration.
Explain:

[__] B1. The research involves no more than minimal risk to the subjects;
Explain:

[__] B2. The waiver or alteration will not adversely affect the rights and welfare of the subjects;
Explain:

[__] B3. The research could not practicably be carried out without the waiver or alteration; and
Explain:

[__] B4. Whenever appropriate, the subjects will be provided with additional pertinent information
after participation.
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Explain:

SECTION K: Request to Waive Documentation of Informed Consent
Section Notes…
• Complete this section if you are requesting a Waiver to Document Informed Consent.
o I.E., the research participant is not signing the consent form.
• Skip this section if you are not requesting a Waiver to Document Informed Consent.
• Answer all A’s OR all B’s
o If A1, A2, or A3 is marked “No”, a request to waive documentation of informed
consent cannot be granted.
o If B1 or B2 is marked “Yes”, a request to waive documentation of informed consent
cannot be granted.
K1. Answer A’s OR B’s
A1. If consent was documented, would the only record linking the subject and the research be the
informed consent form?
[__] Yes
[__] No
A2. If consent was documented, would the principal risk to the subject be the potential harm from a
breach of confidentiality?
[__] Yes
[__] No
A3. Will each subject be asked whether he/she wants documentation linking the subject with the
research, and the subjects wishes will govern?
[__] Yes
[__] No
B1. Does the research present more than minimal risk of harm to subjects?
[__] Yes
[__] No
B2. Are any procedures involved for which written consent is normally required outside of the research
context?
[__] Yes
[__] No
SECTION L: Assent for Minors
Section Notes…
• Permission (consent) of a parent or legally authorized representative must be obtained. Under
certain limited conditions it may be possible for the minor to consent on her/his own behalf,
without the need for parental permission. For example research concerning neglect and abuse.
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L1. The assent will be for (select all that apply):
[__] a. Minors who are not wards of the state or other agency
[__] b. Minors who are wards of the state or other agency
SECTION M: Subject Incentives/ Compensations
Section Notes…
• If you intend to submit to the Travel Management Office for reimbursement purposes make sure
you understand what each level of payment confidentiality means (click here for additional
information).
o Level 1:
 The payee's name, address, and social security number and the amount paid
must be recorded.
 When Level 1 is selected, a formal notice is not issued by the IRB and the
Travel Management Office assumes Level 1.
 Level 1 payment information will be retained in the extramural account folder
at UWM/Research Services and attached to the voucher in Accounts Payable.
These are public documents, potentially open to public review.
o Level 2:
 A list of names, social security numbers, home addresses and amounts paid.
 When Level 2 is selected, a formal notice will be issued by the IRB.
 Level 2 payment information, including the names, are attached to the PIR and
become part of the voucher in Accounts Payable. The records retained by
Accounts Payable are not considered public record.
o Level 3:
 Payments are made to the research subjects by either personal check or cash.
 Gift cards are considered cash.
 If a cash payment is made, the PI must obtain signed receipts.
 The PI shall maintain a record of the research subject's name and
corresponding coded identification. This will be the only record of payee
names, and it will stay in the control of the PI.
M1. Does this study involve incentives or compensation to the subjects? For example cash, class extra
credit, gift cards, or items.
[_x_] Yes
[__] No
M1a. If applicable, select the appropriate confidentiality level for payments (see section notes):
[_x_] Level 1 indicates that confidentiality of the subjects is not a serious issue, e.g., providing a
social security number or other identifying information for payment would not pose a
serious risk to subjects.
[__] Level 2 indicates that confidentiality is an issue, but is not paramount to the study, e.g., the
participant will be involved in a study researching sensitive, yet not illegal issues. For
example, a study of individuals with contagious diseases would fall into this category.
[__] Level 3 indicates that confidentiality of the subjects must be guaranteed. In this category,
identifying information such as a social security number would put a subject at
increased risk. An example of this type of study would be any research involving
illegal activity.

SECTION N: HIPAA and Protected Health Information (PHI)
What is it?
The Health Information Portability and Accountability Act (HIPAA) Privacy Rule is Federal legislation
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which regulates the way certain health care groups, organizations, or businesses, handle the individually
identifiable health information known as protected health information (PHI). The Privacy Rule
establishes the conditions under which covered entities can use or disclose PHI for many purposes,
including for research. Researchers seeking to use PHI from a UWM Covered Department or an external
covered entity as part of their research study must comply with HIPAA. Compliance typically requires
either obtaining a HIPAA Authorization during the informed consent process or obtaining a Waiver of
such Authorization from the IRB.
What is PHI?
Protected health information (PHI) includes information relating to an individual's past, present or future
physical or mental health or condition, the provision of health care services or the past, present or future
payment for such services. It only covers information that is individually identifiable. There are 18
identifiers under the Privacy Rule, some of which include: names, dates, geographic locations, telephone
numbers, medical record numbers, account numbers, biometric identifiers, and other unique identifying
number or code.
What are UWM’s Covered Departments?
UWM is considered a "hybrid entity" under HIPAA because it has some departments and units that are
covered by HIPAA and some that are not. All employees and volunteers in UWM's Covered Departments
must comply with the Privacy and Security Rules, including in connection with research.
UWM's Covered Departments are currently comprised of the following entities:
A. Provider Units:
1. Athletics Trainers (Division of Student Affairs)
2. Hearing Evaluation Center ( College of Health Science)
3. Norris Student Health Center (Division of Student Affairs)
4. Psychology Clinic (College of Letters and Sciences)
5. Speech and Language Clinic ( College of Health Sciences)
6. Urban Health Partnerships ( College of Nursing )

B. Administrative Units:
1. Bursar's Office (Division of Finance & Administrative Affairs)
2. IT Personnel in Business & Financial Services (Division of Academic Affairs)
3. Information and Media Technologies (I&MT) (Division of Academic Affairs)
4. Institutional Review Board Members and Administrative Staff (Division of Finance &
Administrative Affairs)
5. Internal Audit (Division of Finance & Administrative Affairs)
6. Office of Legal Affairs (Division of Finance & Administrative Affairs)
7. Risk Management (Division of Finance & Administrative Affairs)
8. Privacy Officers
How do I know if I am using PHI as part of my research study and have to comply with HIPAA?
If you answer “yes” to any of the below questions, you are using PHI:
Are you accessing or using a participant’s health information from a UWM Covered Department or an
external covered entity (such as a hospital, clinic or other health care agency)?
Are you conducting research in connection or collaboration with an entity covered by HIPAA?
Are you using information from a database that was created using health care information obtained by a
UWM Covered Department or external covered entity?
Note: If you are asking a participant to self-report his medical history outside a clinical/hospital setting
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and do not wish to see his/her medical record, you do not need to obtain the required HIPAA
Authorization or Waiver unless you answer “yes” to one of the above questions.
If you answered yes to any of the questions above, you must either obtain either an “Authorization Form
for Research For the Use and Disclosure of Patient Health Information” from your Research Participants
or IRB approval of an “Application for IRB Waiver of Authorization or Altered Authorization under the
HIPAA Privacy Rule.” You also must complete online HIPAA training at www.hipaa.uwm.edu.
Who do I contact to for more information on this?
Contact the UWM Office of Legal Affairs (https://www4.uwm.edu/legal/hipaa/)

SECTION O: Principal Investigator and Student Principal Investigator Assurances
As Principal and Student Principal Investigator, I certify the following:
•
•
•
•
•
•
•
•
•
•
•

I have reviewed this protocol submission and acknowledge my responsibilities as Principal
Investigator.
The information in this submission accurately reflects the proposed research.
I will not initiate this study until I receive written approval from the IRB.
I will promptly report to the IRB any unanticipated problems and adverse events, as well as any
findings during the course of the study that may affect the risks and benefits to the subjects.
I will obtain prior written approval for modifications (amendments) to this protocol including,
but not limited to, changes in procedures.
I have completed the UWM Human Subjects Training Module.
I have determined whether or not I am accessing protected health information as part of my
proposed research, and if so, I accept responsibility for assuring adherence to HIPAA.
If I am using PHI in my research, I have visited the UWM HIPAA Training website
(www.hipaa.uwm.edu) and have completed all required training, and I am complying with
HIPAA’s requirements for researchers.
I accept responsibility for assuring adherence to applicable Federal and State research regulations
and UWM polices relative to the protection of the rights and welfare of the subjects enrolled in
this study.
I understand that the UWM IRB operates under a Federal Wide Assurance (FWA) from the
Department of Health and Human Services.
Unless given Exempt Status, I understand that this study is subject to continuing review and
approval by the IRB.

Kurt Beschorner _____________________________
Principal Investigator (PRINT NAME)
__________________________________________
DATE

__________________________________________
Student Principal Investigator (PRINT NAME)

__________________________________________
DATE
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Department of University Safety & Assurances

NewStudy-NoticeofIRBExpedited Approval
Date:
To:
Dept:
Cc:
IRB#:
Title:

October 12, 2010
Kurt Beschorner, Ph.D.
Industrial Engineering
-------11.069
Role of Bifocal Lens Glasses on Walking Balance

Melissa Spadanuda IRB Administrator Institutional Review Board Engelmann 270
P. O. Box 413
Milwaukee, WI 53201-0413 (414) 229-3173 phone
(414) 229-6729 fax
http://www.irb.uwm.edu spadanud@uwm.edu

After review of your research protocol by the University of Wisconsin – Milwaukee
Institutional
Review Board, your protocol has been approved as minimal risk Expedited under Category
4 and
7 as governed by 45 CFR 46.110.
This protocol has been approved on October 12, 2010 for one year. IRB
approval will expire on October 11, 2011. If you plan to continue any research
related activities (e.g., enrollment of subjects, study interventions, data analysis,
etc.) past the date of IRB expiration, a continuation for IRB approval must be
filed by the submission deadline. If the study is closed or completed before the
IRB expiration date, please notify the IRB by completing and submitting the
Continuing Review form found on the IRB website.
Unless specifically where the change is necessary to eliminate apparent
immediate hazards to the subjects, any proposed changes to the protocol must be
reviewed by the IRB before implementation. It is the principal investigator’s
responsibility to adhere to the policies and guidelines set forth by the UWM IRB
and maintain proper documentation of its records and promptly report to the IRB
any adverse events which require reporting.
It is the principal investigator’s responsibility to adhere to UWM and UW
System Policies, and any applicable state and federal laws governing activities
the principal investigator may seek to employ (e.g., FERPA, Radiation Safety,
UWM Data Security, UW System policy on Prizes, Awards and Gifts, state
gambling laws, etc.) which are independent of IRB review/approval.
Contact the IRB office if you have any further questions. Thank you for your
cooperation and best wishes for a successful project.
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Respectfully,
Melissa C. Spadanuda
IRB Administrator
CC: Study File
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Department of University Safety & Assurances

Modification/Amendment - IRB Expedited Approval
Benjamin J. Kennedy, MA IRB Manager
Institutional Review Board
Engelmann 270
P. O. Box 413
Milwaukee, WI
53201-0413
(414) 229-3182 phone (414) 229-6729 fax http://www.irb.uwm.edu
kennedbj@uwm.edu

Date:

April 28, 2011

To:
Dept:

Kurt Beschorner, Ph.D.
Industrial Engineering

Cc:

Autumn Milanowski, BS

IRB#: 11.069
Title: Role of Bifocal Lens Glasses on Walking Balance
After review of your research protocol by the University of Wisconsin – Milwaukee Institutional
Review Board, your protocol has received modification/amendment approval for:

•

•
•
•
•
•

• Modify subject age range from 18-35 to 18-60 years of age and include
experienced multifocal lens glasses wearers;
Addition of $30.00 payment to subjects with a Level 2 Confidentiality for subjects.;
• Addition of exclusionary criteria for subjects taking medication that
could affect their ability to walk or balance;
Revised Protocol Summary;
Revised recruitment flyer;
Addition of payment sheet;
Revised Consent; and
Revised phone script.

IRB approval will expire on October 11, 2011. If you plan to continue any research
related activities (e.g., enrollment of subjects, study interventions, data analysis, etc.)
past the date of
IRB expiration, a Continuation for IRB Approval must be filed by the submission
deadline. If the study is closed or completed before the IRB expiration date, please notify
the IRB by completing and submitting the Continuing Review form found on the IRB
website.
Unless specifically where the change is necessary to eliminate apparent immediate
hazards to the subjects, any proposed changes to the protocol must be reviewed by the
IRB before implementation. It is the principal investigator’s responsibility to adhere to
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the policies and guidelines set forth by the UWM IRB and maintain proper
documentation of its records and promptly report to the IRB any adverse events which
require reporting.
It is the principal investigator’s responsibility to adhere to UWM and UW System
Policies, and any applicable state and federal laws governing activities the principal
investigator may seek to employ (e.g., FERPA, RadiationSafety, UWMDataSecurity,
UWSystempolicyonPrizes, AwardsandGifts, State gaming laws, etc.) which are
independent of IRB review/approval.
Contact the IRB office if you have any further questions. Thank you for your cooperation
and best wishes for a successful project.

Respectfully,
Benjamin J. Kennedy
IRB Manager
CC: Study File
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Modifications/ Amendment Form
Instructions: Each Section must be completed unless directed otherwise. Incomplete forms will delay the
IRB review process and may be returned to you. Enter your information in the colored boxes or place an
“X” in front of the appropriate response(s).
Amendment submissions with IRB# of 09.210 and higher (e.g., 09.215, 09.300, 10.010) may be submitted
electronically by email to irbinfo@uwm.edu. Type "Amendment Submission" in the subject line. All other
Amendment submissions with IRB# 09.209 and lower (e.g., 03.02.052, 05.02.200, 07.02.350, 08.325,
09.199) must submit 3 collated copies in paper (2 copies + 1 signed original).
SECTION A: Title & Date
Section Notes…
• A1. Study title must be the same on all study documents (e.g., consents, advertisements, grants,
etc.).
A1. Study
Title:

Role of Bifocal Lens Glasses on Walking Balance

A2. IRB#:

11.069
A2. Today’s Date:

A3. Principal Investigator (P.I.):
Name:

Kurt Beschorner

Degree(s):

PhD

Title/Position:

Assistant Professor

Department:

Industrial Engineering

Telephone:

414-229-6403

Email:

beschorn@uwm.edu

A4. Student Principal Investigator (S.P.I.) or Other Contact than PI:
Name:

Autumn Milanowski

Telephone:

Degree(s):

BS

Email:

Milanow2@uwm.edu

SECTION B: Modification/ Amendment Type
Section Notes…
• Remember to update and submit any materials which may be affected by the proposed
amendment. For instance, if the requested change is add additional study procedures, the
Protocol Summary Form and Consent Form may need to be updated as well.
• If “Minor Amendment” was selected, submit 3 copies (2 showing track changes, 1 clean version
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•

showing revisions).
If “Major Amendment” was selected, submit 14 copies (13 showing track changes, 1 clean
version showing revisions)

B1. What is the nature of the modification/ amendment request? See “Section Notes” for required
materials to submit.
[_x_] a. A Minor Amendment which does NOT alter the risk to benefit ratio of the study and does NOT
significantly change the study design/procedures. Examples include but are not limited to:
•

changes in research personnel;

•

administrative updates to protocol, consent, etc.;

•

addition of recruitment materials

•

increasing sample size; and

•

small compensation to participants.

[__] b. A Major Amendment which DOES alter the risk to benefit ratio of the study and DOES
significantly change the study design/procedures. Examples include but are not limited to:
•

additional risks have been identified;

•

a significant change to compensation; and

•

length of participant involvement significantly increase.

SECTION C: Description of the Modification/ Amendment
Section Notes…
• If the modification/ amendment is for a change in PI or study coordinator, include their contact
information (name, department, phone, fax, address, and email).
C1. Describe the requested modification/ amendment.
The modifications include changing the participant total to 40 and excluding ages 35-45.

SECTION D: Rationale for Modification/ Amendment
Section Notes…
• D2. If currently enrolled participants are unaffected by the modification/ amendment or consent
is not obtained from subjects, explain below.
Example: The amendment is for a change in co-investigator who does not interact with the
subjects.
Example: The amendment is an administrative change and this study is an anonymous telephone
survey.
Example: The amendment is to revise the study design to include an additional intervention. The
subjects will be re-consented at the time of their next study visit using the revised
consent form which is being submitted for IRB approval along with this amendment
request.
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D1. Explain the rationale for the proposed modification/ amendment below.
The age range will exclude ages 35-45 because the researchers want to investigate a younger and
older population. The total number of participants was increased to allow additional participants in
each age group.
D2. Explain how the new information (modification/ amendment) will be communicated to currently
enrolled subjects?
The additional exclusion criteria will be added to the recruitment materials.

SECTION E: Principal Investigator Signature

__________________________________________
Principal Investigator (PRINT NAME)

__________________________________________
Principal Investigator (SIGNATURE)

__________________________________________
DATE

__________________________________________
DATE

__________________________________________
Student Principal Investigator (PRINT NAME)
(SIGNATURE)

__________________________________________
Student Principal Investigator

__________________________________________
DATE

__________________________________________
DATE

Reminders: Make sure all questions that are applicable have been answered on this form. To avoid
automatic IRB termination of your study, request for Continuing Review should be submitted no later than
one month before the date of IRB expiration.
Amendment submissions with IRB# of 09.210 and higher (e.g., 09.215, 09.300, 10.010) may be submitted
electronically by email to irbinfo@uwm.edu. Type "Amendment Submission" in the subject line. All other
Amendment submissions with IRB# 09.209 and lower (e.g., 03.02.052, 05.02.200, 07.02.350, 08.325,
09.199) must submit 3 collated copies in paper (2 copies + 1 signed original).

Modifications/ Amendment Form
Instructions: Each Section must be completed unless directed otherwise. Incomplete forms will delay the
IRB review process and may be returned to you. Enter your information in the colored boxes or place an
“X” in front of the appropriate response(s).
Amendment submissions with IRB# of 09.210 and higher (e.g., 09.215, 09.300, 10.010) may be submitted
electronically by email to irbinfo@uwm.edu. Type "Amendment Submission" in the subject line. All other
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Amendment submissions with IRB# 09.209 and lower (e.g., 03.02.052, 05.02.200, 07.02.350, 08.325,
09.199) must submit 3 collated copies in paper (2 copies + 1 signed original).
SECTION A: Title & Date
Section Notes…
• A1. Study title must be the same on all study documents (e.g., consents, advertisements, grants,
etc.).
A1. Study
Title:

Role of Bifocal Lens Glasses on Walking Balance

A2. IRB#:
11.069
A2. Today’s Date:

A3. Principal Investigator (P.I.):
Name:

Kurt Beschorner

Degree(s):

PhD

Title/Position:

Assistant Professor

Department:

Industrial Engineering

Telephone:

414-229-6403

Email:

beschorn@uwm.edu

A4. Student Principal Investigator (S.P.I.) or Other Contact than PI:
Name:

Autumn Milanowski

Telephone:

Degree(s):

BS

Email:

Milanow2@uwm.edu

SECTION B: Modification/ Amendment Type
Section Notes…
• Remember to update and submit any materials which may be affected by the proposed
amendment. For instance, if the requested change is add additional study procedures, the
Protocol Summary Form and Consent Form may need to be updated as well.
• If “Minor Amendment” was selected, submit 3 copies (2 showing track changes, 1 clean version
showing revisions).
• If “Major Amendment” was selected, submit 14 copies (13 showing track changes, 1 clean
version showing revisions)
B1. What is the nature of the modification/ amendment request? See “Section Notes” for required
materials to submit.
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[_x_] a. A Minor Amendment which does NOT alter the risk to benefit ratio of the study and does NOT
significantly change the study design/procedures. Examples include but are not limited to:
•

changes in research personnel;

•

administrative updates to protocol, consent, etc.;

•

addition of recruitment materials

•

increasing sample size; and

•

small compensation to participants.

[__] b. A Major Amendment which DOES alter the risk to benefit ratio of the study and DOES
significantly change the study design/procedures. Examples include but are not limited to:
•

additional risks have been identified;

•

a significant change to compensation; and

•

length of participant involvement significantly increase.

SECTION C: Description of the Modification/ Amendment
Section Notes…
• If the modification/ amendment is for a change in PI or study coordinator, include their contact
information (name, department, phone, fax, address, and email).
C1. Describe the requested modification/ amendment.
The modifications include changing the age range and eligibility on the recruitment flier.

SECTION D: Rationale for Modification/ Amendment
Section Notes…
• D2. If currently enrolled participants are unaffected by the modification/ amendment or consent is
not obtained from subjects, explain below.
Example: The amendment is for a change in co-investigator who does not interact with the
subjects.
Example: The amendment is an administrative change and this study is an anonymous telephone
survey.
Example: The amendment is to revise the study design to include an additional intervention. The
subjects will be re-consented at the time of their next study visit using the revised
consent form which is being submitted for IRB approval along with this amendment
request.
D1. Explain the rationale for the proposed modification/ amendment below.
The researchers are recruiting only ages 45-60 because all younger subjects have been recruited. The
eligibility has been changed because bifocal wearers are not needed and participants can wear reading
glasses or contacts.
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D2. Explain how the new information (modification/ amendment) will be communicated to currently
enrolled subjects?
Changes will be made to the recruitment materials.

SECTION E: Principal Investigator Signature

__________________________________________
Principal Investigator (PRINT NAME)

__________________________________________
Principal Investigator (SIGNATURE)

__________________________________________
DATE

__________________________________________
DATE

__________________________________________
Student Principal Investigator (PRINT NAME)
(SIGNATURE)

__________________________________________
Student Principal Investigator

__________________________________________
DATE

__________________________________________
DATE

Reminders: Make sure all questions that are applicable have been answered on this form. To avoid
automatic IRB termination of your study, request for Continuing Review should be submitted no later than
one month before the date of IRB expiration.
Amendment submissions with IRB# of 09.210 and higher (e.g., 09.215, 09.300, 10.010) may be submitted
electronically by email to irbinfo@uwm.edu. Type "Amendment Submission" in the subject line. All other
Amendment submissions with IRB# 09.209 and lower (e.g., 03.02.052, 05.02.200, 07.02.350, 08.325,
09.199) must submit 3 collated copies in paper (2 copies + 1 signed original).
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Department of University Safety & Assurances

ContinuingReview-NoticeofIRBExpedited Approval
Benjamin J. Kennedy, MA IRB Manager
Institutional Review Board
Engelmann 270
P. O. Box 413
Milwaukee, WI
53201-0413
(414) 229-3182 phone (414) 229-6729 fax http://www.irb.uwm.edu
kennedbj@uwm.edu

Date:

October 7, 2011

To:
Dept:

Kurt Beschorner, Ph.D.
Industrial Engineering

Cc:

--------

IRB#: 11.069
Title: Role of Bifocal Lens Glasses on Walking Balance
After review of your research protocol by the University of Wisconsin – Milwaukee
Institutional Review Board, your protocol has received continuing approval as minimal
risk Expedited under category 4 & 7 as governed by 45 CFR 46.110.
This protocol has been approved on October 7, 2011 for one year. IRB approval will
expire on October 6, 2012. If you plan to continue any research related activities (e.g.,
enrollment of subjects, study interventions, data analysis, etc.) past the date of IRB
expiration, a Continuation for IRB Approval must be filed by the submission deadline.
If the study is closed or completed before the IRB expiration date, please notify the
IRB by completing and submitting the Continuing Review form found on the IRB
website.
Unless specifically where the change is necessary to eliminate apparent immediate
hazards to the subjects, any proposed changes to the protocol must be reviewed by the
IRB before implementation. It is the principal investigator’s responsibility to adhere to
the policies and guidelines set forth by the UWM IRB and maintain proper
documentation of its records and promptly report to the IRB any adverse events which
require reporting.
It is the principal investigator’s responsibility to adhere to UWM and UW System
Policies, and any applicable state and federal laws governing activities the principal
investigator may seek to employ (e.g., FERPA, RadiationSafety, UWMDataSecurity,
UWSystempolicyonPrizes, AwardsandGifts, State gaming laws, etc.) which are
independent of IRB review/approval.

117
Contact the IRB office if you have any further questions. Thank you for your
cooperation and best wishes for a successful project.

Respectfully,
Benjamin J. Kennedy
IRB Manager
CC: Study File
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Appendix I: Equivalent Text Descriptions
1. Table 1 EqTD
Table 1. Mean and standard deviation demographic information for young and middleaged groups
Brief Description: Table showing the demographic information for both middle-aged
and young participants.
Essential Description: The author included this table to provide the reader with specific
information on the participants age, gender, weight, and height.
Detailed Description: The table consists of 5 columns and 6 rows. The first column lists
gender, age, weight, and height. The first row lists both groups both middle-aged and
young individuals. The second row contains the headings mean and standard deviation
for both young and middle-aged groups. Columns 2-5 contains the means and standard
deviations.
2. Table 2 EqTD
Table 2. Displays the DGI-m results of the paired t-test data for within subjects
Brief Description: Table showing the DGI-m mean and t-test results for young and
middle-aged within subjects.
Essential Description: The author included this table to provide the reader with specific
information on of the within group t-tests and means
Detailed Description: The table consists of 5 columns and 4 rows. The first column lists
the within subjects and the groups young and middle-aged. The first row lists mean for
progressive lens, mean for single lens, t-test, and p-value. Rows 2-4 list all the results of
the within groups.
3. Table 3 EqTD
Table 3. Displays the toe clearance results of the paired t-test data for within subjects
Brief Description: Table showing the toe clearance mean and t-test results for young and
middle-aged within subjects.
Essential Description: The author included this table to provide the reader with specific
information on of the within group t-tests and means
Detailed Description: The table consists of 5 columns and 4 rows. The first column lists
the within subjects and the groups young and middle-aged. The first row lists mean for
progressive lens, mean for single lens, t-test, and p-value. Rows 2-4 list all the results of
the within groups.
4. Table 4 EqTD
Table 4. Displays the force results of the paired t-test data for within subject
Brief Description: Table showing the force mean and t-test results for young and
middle-aged within subjects.
Essential Description: The author included this table to provide the reader with specific
information on of the within group t-tests and means
Detailed Description: The table consists of 5 columns and 4 rows. The first column lists
the within subjects and the groups young and middle-aged. The first row lists mean for
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progressive lens, mean for single lens, t-test, and p-value. Rows 2-4 list all the results of
the within groups.
5. Figure 1 EqTD
Figure 1. a) Progressive lens regions and b) view through progressive lens
Brief Description: Picture a) shows the three regions of a progressive lens and b) shows
the distorted view when looking through a progressive lens.
Essential Description: The author included these pictures to provide the reader with a
visual of what is included in a progressive lens and how the distortion can affect vision.
Detailed Description: Picture a) shows the progressive lens with three regions. Top
region is for far viewing, middle region is for mid viewing, and lower region is for
reading viewing. The blurry regions of the sides represent the distortion caused by
grinding the regions together to remove the lines. Picture b) is a looking through a
progressive lens at a stair. The stair is distorted and curved due to the lens.
6. Figure 2 EqTD
Figure 2. Bar graph depicting DGI-m means for single and MfLs within group
Brief Description: This bar graph shows two bars per group (young and middle-aged)
which illustrate the means of MfLs and single lenses.
Essential Description: The author included this bar graph to provide the reader with a
visual of the difference between MfL and single lens means within each group. For DGIm scores there is a decrease in score for MfLs in both groups.
Detailed Description: There are four bars. The pink bars represent MfLs and the blue
bars represent single lenses. The x-axis contains young and middle-aged groups. Each
group has a blue and pink bar to represent within group change. The MfLs bar is lower
than the single lens bar representing higher DGI-m scores for MfLs in both groups. The
highest number on the y-axis is 50.
7. Figure 3 EqTD
Figure 3. Bar graph depicting DGI-m means for single and MfLs between groups
Brief Description: This bar graph shows two bars per group (MfLs and single lenses) which illustrate the differences between groups (middle-aged and young).
Essential Description: The author included this bar graph to provide the reader with a
visual of the difference between MfL and single lens means between each group. For
DGI-m scores there is no difference between group single and MfL scores.
Detailed Description: There are four bars. The green bars represent middle-aged and the
blue bars represent young. The x-axis contains MfLs and single lenses. Each lens has a
green and blue bar to represent between group change. Both green and blue bars are
similar heights representing no difference between groups. The highest number on the yaxis is 50.
8. Figure 4 EqTD
Figure 4. Bar graph depicting toe clearance means for single and MfLs within groups
Brief Description: This bar graph shows two bars per group (young and middle-aged)
which illustrate the means of MfLs and single lenses.
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Essential Description: The author included this bar graph to provide the reader with a
visual of the difference between MfL and single lens means within each group. For toe
clearance scores there is a decrease in score for MfLs in both groups.
Detailed Description: There are four bars. The pink bars represent MfLs and the blue
bars represent single lenses. The x-axis contains young and middle-aged groups. Each
group has a blue and pink bar to represent within group change. The MfLs bar is higher
than the single lens bar representing higher toe clearance scores for MfLs in both groups.
The highest number on the y-axis is 200.
9. Figure 5 EqTD
Figure 5. Bar graph depicting toe clearance means for single and MfLs between groups
Brief Description: This bar graph shows two bars per group (MfLs and single lenses) which illustrate the differences between groups (middle-aged and young).
Essential Description: The author included this bar graph to provide the reader with a
visual of the difference between MfL and single lens means between each group. For toe
clearance scores there is no difference between group single and MfL scores.
Detailed Description: There are four bars. The green bars represent middle-aged and the
blue bars represent young. The x-axis contains MfLs and single lenses. Each lens has a
green and blue bar to represent between group change. Both green and blue bars are
similar heights representing no difference between groups. The highest number on the yaxis is 200.
10. Figure 6 EqTD
Figure 6. Bar graph depicting force means for single and MfLs within groups
Brief Description: This bar graph shows two bars per group (young and middle-aged)
which illustrate the means of MfLs and single lenses.
Essential Description: The author included this bar graph to provide the reader with a
visual of the difference between MfL and single lens means within each group. Force
scores no change between bars.
Detailed Description: There are four bars. The pink bars represent MfLs and the blue
bars represent single lenses. The x-axis contains young and middle-aged groups. Each
group has a blue and pink bar to represent within group change. The MfLs bar is slightly
higher than the single lens bar indicating no significant change in force when switching
lenses. The highest number on the y-axis is 2.0.
11. Figure 7 EqTD
Figure 7. Bar graph depicting force means for single and MfLs between groups
Brief Description: This bar graph shows two bars per group (MfLs and single lenses) which illustrate the differences between groups (middle-aged and young).
Essential Description: The author included this bar graph to provide the reader with a
visual of the difference between MfL and single lens means between each group. For
force scores there is no difference between group single and MfL scores.
Detailed Description: There are four bars. The green bars represent middle-aged and the
blue bars represent young. The x-axis contains MfLs and single lenses. Each lens has a
green and blue bar to represent between group change. Both green and blue bars are
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similar heights representing no difference between groups. The highest number on the yaxis is 2.0.
12. Appendix A.1 EqTD
Figure 1. a) Progressive lens regions and b) view through progressive lens
Brief Description: Picture a) shows the three regions of a progressive lens and b) shows
the distorted view when looking through a progressive lens.
Essential Description: The author included these pictures to provide the reader with a
visual of what is included in a progressive lens and how the distortion can affect vision.
Detailed Description: Picture a) shows the progressive lens with three regions. Top
region is for far viewing, middle region is for mid viewing, and lower region is for
reading viewing. The blurry regions of the sides represent the distortion caused by
grinding the regions together to remove the lines. Picture b) is a looking through a
progressive lens at a stair. The stair is distorted and curved due to the lens.
13. Appendix A.2 EqTD
Research hypotheses design figure
Brief Description: Figure represents hypothesis one, two, and three through boxes and
arrows.
Essential Description: The author included this figure to provide the reader with a visual
to better understand the hypotheses.
Detailed Description: The top two boxes represent hypothesis one which is the switch
between lenses in young novice wearers. The bottom two boxes represent hypothesis two
which is the switch between lenses in middle-aged novice wearers. The arrow connecting
the change between the switch of lenses represents hypothesis three which is the
comparison between the two group changes when switching lenses. The circles represent
the three biomechanical variables and the DGI-m.
14. Appendix A.3 EqTD
Table of participant group demographics
Brief Description: Table represents each group demographics. Shows that the two
groups are middle-aged and young, both are novice wearers, and they both will be
wearing single and MfL glasses.
Essential Description: The author included this figure to provide the reader with a visual
to better understand the two groups.
Detailed Description: The table contains 3 rows and 4 columns. The first row contains
group, age, experience, and glasses. The first column contains group one and two. The
column under age includes young and middle-aged. The column under experience
includes novice for both and the column under glasses contains MfL/single for both.
15. Appendix A.4 EqTD
Participant stepping over a shoebox as one of the DGI-m tasks.
Brief Description: Picture represents the shoebox task for the DGI-m.
Essential Description: The author included this figure to provide the reader with a visual
of a participant performing one of the DGI-m tasks.
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Detailed Description: The participant is in mid-step when walking down a gridded
runway. The participant is stepping over a show box. The participant is wearing lenses
and motion capture markers.
16. Appendix A.5 EqTD
Picture of a participant’s lower body with motion capture markers
Brief Description: Picture represents participant with motion capture markers on their
leg.
Essential Description: The author included this figure to provide the reader with a visual
of where the markers are located on the participant’s legs.
Detailed Description: There are 7 markers on the side of one leg. There are 3 markers on
the side of the middle of the thigh, one marker on the lateral knee, and 3 markers on the
side of the middle of the calf.
17. Appendix A.6 EqTD
Picture of the flow of DGI-m tasks.
Brief Description: Picture represents the order of DGI-m tasks.
Essential Description: The author included this figure to provide the reader with a visual
the clearly order the DGI-m tasks.
Detailed Description: The DGI-m consists of nine walking tasks. These include:
walking at normal speed, changing speeds, turning the head horizontally while walking,
turning the head vertically, walking then pivoting, stepping over a shoebox and diagonal
long box, stepping around cones, and stepping on and off a platform.
18. Appendix A.7 EqTD
Represents the within and between group analysis
Brief Description: Shows the data analysis for the variables DGI-m, toe clearance, and
normal force. The raw scores are compared for the within group analysis and the
difference between mean scores are compared for the between analysis.
Essential Description: The author included this figure to provide the reader with a visual
that clearly represents the within and between data analysis for each variable. It also
represents the raw scores and means needed for each test.
Detailed Description: Brief Description: Picture represents the order of DGI-m tasks.
Essential Description: The author included this figure to provide the reader with a visual
the clearly order the DGI-m tasks.
Detailed Description: There are 5 rows and 3 columns. The first row contains within and
between analysis. The second row contains the variable and the switch between single
and MfL glasses for each within and between group analysis. Column one contains the
variables of DGI-m, toe clearance, and normal force. The within group analysis compares
raw scores and the between group analysis compares mean scores of each group.

